[{"Date":"2004-09-24T00:00:00.000","Headline":"\"A Very Iffy Period for Stocks\"","Summary":"That's what S&P's Joseph Lisanti sees, at least until after the election -- but there are still some buys out there"},{"Date":"2004-10-04T00:00:00.000","Headline":"A New Owner For Aspect?","Summary":"By Gene G. Marcial"},{"Date":"2004-10-08T00:00:00.000","Headline":"Double-Barrel Stocks","Summary":"Looking for shares that offer a juicy dividend yield and promising capital appreciation? These 20 manage to do both"},{"Date":"2004-10-08T00:00:00.000","Headline":"How Serious Is Pfizer's Condition?","Summary":"The stock is feeling some pain these days. However, this drugmaker has enough going for it that the illness shouldn't last"},{"Date":"2004-10-12T00:00:00.000","Headline":"S&P Upgrades Nextel to Buy","Summary":"Also: analysts' opinions on State Street and Eli Lilly. Plus more"},{"Date":"2004-10-18T00:00:00.000","Headline":"Robert Swanson and Herbert Boyer: Giving Birth To Biotech","Summary":"A venture capitalist and a scientist changed how drugs are made"},{"Date":"2004-10-20T00:00:00.000","Headline":"Stocks Finish Mixed","Summary":"Blue chips slumped, while the Nasdaq edged higher, as crude prices surged on lower-than-expected oil inventories"},{"Date":"2004-10-21T00:00:00.000","Headline":"Google Shows Profit","Summary":"Microsoft gains; Amazon disappoints; plus more of Thursday's stocks in the news"},{"Date":"2004-10-21T00:00:00.000","Headline":"Stocks Finish Mixed","Summary":"EBay's strong profits lift the Nasdaq, while the Dow was dragged down by AIG"},{"Date":"2004-10-26T00:00:00.000","Headline":"AIG, Other Insurers Rise on Marsh News","Summary":"Qualcomm shares dip after downgrade; Omnicom net rises; plus more of Tuesday's stocks in the news"},{"Date":"2004-10-28T00:00:00.000","Headline":"Can Intrinsa Be a Viagra for Women?","Summary":"Procter & Gamble may be first to win approval for a testosterone skin patch to boost female desire, especially for menopausal users"},{"Date":"2004-11-03T00:00:00.000","Headline":"Ballard, Cogent, LaCrosse, PacifiCare: U.S. Equity Movers Final","Summary":"Shares of these companies had unusual price changes in U.S. markets as of 4:15 p.m. New York time. Stock symbols are in parentheses after company names."},{"Date":"2004-11-08T00:00:00.000","Headline":"Drug Ads -- Without Harmful Side Effects","Summary":"As Vioxx shows, pitching medicines directly to consumers has serious drawbacks. Here are some innovative ways to get info out -- safely"},{"Date":"2004-11-10T00:00:00.000","Headline":"Accounting's Beautiful Losers","Summary":"Big firms and small battled Sarbanes-Oxley and failed. Now they're finding it's a source of unexpectedly lucrative rewards"},{"Date":"2004-11-17T00:00:00.000","Headline":"Viagra: A Drug Ad Too Far?","Summary":"Pfizer pulled a pitch for the product under FDA pressure, but with the watchdog overwhelmed, drugmakers likely won't stop pushing the envelope"},{"Date":"2004-11-29T00:00:00.000","Headline":"Table: How Corporations Hand It Out","Summary":"* Cash gifts as reported to BusinessWeek; this % is only available for companies that participated in our survey last year"},{"Date":"2004-12-09T00:00:00.000","Headline":"Nextel, Sprint Rise on Merger Speculation","Summary":"Altera and Xilinx fall on lowered revenue forecasts; P&G climbs; plus more of Thursday's stocks in the news"},{"Date":"2004-12-09T00:00:00.000","Headline":"S&P: Still Hold Xilinx","Summary":"Plus analysts' opinions on Altera, P&G, Cisco, and more"},{"Date":"2004-12-13T00:00:00.000","Headline":"Go East, Big Pharma","Summary":"Drugmakers are expanding in China, but patents are still a worry"},{"Date":"2004-12-17T00:00:00.000","Headline":"Pfizer Falls on Celebrex News","Summary":"AstraZeneca shares drop on unfavorable cancer-drug study; PalmOne declines on lowered third-quarter guidance; plus more of Friday's stocks in the news"},{"Date":"2004-12-27T00:00:00.000","Headline":"Candor Can Immunize Big Pharma","Summary":"The drug industry needs to release and publicize all research studies, including negative ones, if it wants to avoid another Vioxx debacle"},{"Date":"2004-12-27T00:00:00.000","Headline":"A Billionaire For Berkshire","Summary":"Adding another independent voice to its board, Berkshire Hathaway (BRK) directors elected Microsoft (MSFT) Chairman Bill Gates to join them. The Dec. 14 move may do little to stem criticism that Berkshire is too insular, since Gates is close with Chairman Warren Buffett. But all but four of Berkshire's 11 directors are now outsiders. The board position is Gates's third, besides seats at Microsoft and Bothell (Wash.) biotech company Icos (ICOS), which markets the erectile-dysfunction drug Cialis"},{"Date":"2004-12-31T00:00:00.000","Headline":"Stocks End Year on a Down Note","Summary":"Negative corporate news pressured equities in the year's last trading session, but the major indexes finished up for 2005 overall"},{"Date":"2005-01-10T00:00:00.000","Headline":"More Bitter Pills For Big Pharma","Summary":"-- Patents are expiring on blockbuster drugs, and there's not much in the pipelines\r -- Executives fear that Washington will get tough in the wake of the Vioxx debacle"},{"Date":"2005-01-13T00:00:00.000","Headline":"Sun Micro Misses Revenue Estimates","Summary":"Apple soars on first-quarter results; Harmonic's sales exceed guidance; plus more of Thursday's stocks in the news"},{"Date":"2005-01-14T00:00:00.000","Headline":"Gates Skates, LeapFrog Leaps","Summary":"Bill leaves Icos' board for Berkshire Hathaway's. LeapFrog launches a computer pen. Intel's internal blogger. And more"},{"Date":"2005-01-21T00:00:00.000","Headline":"Vital Signs for the Week of Jan. 24","Summary":"On tap: January's consumer confidence, December's durable-goods orders, fourth-quarter reports on employment costs and GDP, and more"},{"Date":"2005-01-25T00:00:00.000","Headline":"Simple, Straightforward Investing","Summary":"It's not exciting, but the results have been exciting, Farr, Miller & Washington's chief says of his growth-at-a-reasonable-price approach"},{"Date":"2005-01-26T00:00:00.000","Headline":"Stocks Finish Higher","Summary":"Another round of better than expected earnings reports boosted the market"},{"Date":"2005-01-26T00:00:00.000","Headline":"Electronic Arts: Still a Buy","Summary":"S&P says the video-game outfit trades at a discount to its peers. Plus analyst opinions on Texas Instruments, Lilly, and SAP"},{"Date":"2005-02-07T00:00:00.000","Headline":"Investing To Fight Disease","Summary":"It may be better for your soul than for your bottom line"},{"Date":"2005-02-07T00:00:00.000","Headline":"Super Bowl Ads: Less Than Superb","Summary":"The spots showed few winning moves as advertisers and Fox played it safe. But why bother spending big money for the pitches then?"},{"Date":"2005-02-07T00:00:00.000","Headline":"Online Extra: Healthy Investment?","Summary":"For those who want to bet on companies linked to treatment of a"},{"Date":"2005-02-21T00:00:00.000","Headline":"Corporate Scandal And Political Gifts","Summary":"Are companies that make undisclosed political donations bad for shareholders? Yes, says the Center for Political Accountability, a nonpartisan watchdog group. On Feb. 14 the center will unveil a report rating the decision-making and disclosure policies of 120 large companies that donated soft money in 2002 to the independent political groups known as 527 committees. Companies that didn't disclose their gifts were more likely to run into management scandals -- think Enron -- or reputational risk,"},{"Date":"2005-02-23T00:00:00.000","Headline":"\"Risk-Free\" Drugs Don't Exist","Summary":"Eli Lilly CEO Sidney Taurel says he worries the medicine-safety debate is too much on the risks, without weighing them with the benefits"},{"Date":"2005-02-28T00:00:00.000","Headline":"The Little Blue Pill -- And Pals -- Have The Blues","Summary":"Judging by the tons of TV and print ads that pitch erectile dysfunction drugs, you would think the big three -- Viagra, Cialis, and Levitra -- were selling as briskly as beer at a football game. After all, what could be more marketable than a pill that helps aging men perform better in bed?"},{"Date":"2005-03-14T00:00:00.000","Headline":"Sidney Taurel: How To Combat Withdrawal","Summary":"Early in his tenure as Eli Lilly CEO (LLY), Sidney Taurel had his Prozac moment. The antidepressant was accounting for nearly 25% of Lilly's sales. Then, in mid-2001, Prozac lost its U.S. patent protection. Sales sank so low it took Lilly more than a year to bounce back."},{"Date":"2005-03-21T00:00:00.000","Headline":"Outsourcing Innovation","Summary":"First came manufacturing. Now companies are farming out R&D to cut costs and get new products to market faster. Are they going too far?"},{"Date":"2005-04-15T00:00:00.000","Headline":"Stocks Finish with Steep Losses","Summary":"Major indexes fell sharply for the third day in a row on weak economic news and disappointing corporate profits"},{"Date":"2005-04-15T00:00:00.000","Headline":"S&P Downgrades IBM to Hold","Summary":"Plus analysts' opinions on General Electric, Citigroup, Eli Lilly, and more"},{"Date":"2005-04-15T00:00:00.000","Headline":"GE Forecasts Higher Earnings","Summary":"Citigroup posts higher first-quarter profit; Genentech gains on positive data for breast cancer drug; plus more of Friday's stocks in the news"},{"Date":"2005-04-18T00:00:00.000","Headline":"S&P Upgrades Adobe, Macromedia to Buy","Summary":"Plus analysts' opinions on Electronics Boutique, Bank of America, and more"},{"Date":"2005-04-18T00:00:00.000","Headline":"Stocks End Mixed","Summary":"The Dow was hurt by lackluster sales at 3M while upbeat earnings propped up the broader market"},{"Date":"2005-04-18T00:00:00.000","Headline":"Adobe to Buy Macromedia","Summary":"GameStop agrees to acquire Electronics Boutique; Bank of America, 3M post higher earnings; plus more of Monday's stocks in the news"},{"Date":"2005-04-18T00:00:00.000","Headline":"Praying for Good Earnings","Summary":"Though GE's strength couldn't spark a rally, some coming reports hold promise -- as do lower oil prices. This week should be telling"},{"Date":"2005-05-17T00:00:00.000","Headline":"CS First Boston Keeps Merck at Underweight","Summary":"Analyst Catherine Arnold says Merck's recent gross margin trends may be overstated based on her analysis"},{"Date":"2005-06-02T00:00:00.000","Headline":"Biotech, Finally","Summary":"It has been 30 years of promising research and crushing commercial disappointments. Now a burst of breakthroughs may be the tipping point"},{"Date":"2005-06-07T00:00:00.000","Headline":"Large-Caps at Not-so-Big Prices","Summary":"Farr, Miller & Washington's Taylor McGowan makes value his watchword. It's the reason, he says, why he likes Bank of America, GE, and Wells Fargo"},{"Date":"2005-06-10T00:00:00.000","Headline":"Stocks End Mixed","Summary":"The Dow gained on upbeat GM news while the Nasdaq fell on semiconductor weakness. Investors are looking ahead to next week's inflation reports"},{"Date":"2005-06-13T00:00:00.000","Headline":"Biotech, Finally","Summary":"Yes, the business remains risky, but medical progress is stunning."},{"Date":"2005-06-20T00:00:00.000","Headline":"Online Extra: Tour the Collectives of Cyberspace","Summary":"New technologies have people communicating and collaborating on an unprecedented scale. Here's a look at some of the hottest spots"},{"Date":"2005-06-20T00:00:00.000","Headline":"The Power Of Us","Summary":"Mass collaboration on the Internet is shaking up business"},{"Date":"2005-06-27T00:00:00.000","Headline":"Now The Real Value Is In Growth","Summary":"With profits strong, growth stocks are leaving their value cousins behind"},{"Date":"2005-06-27T00:00:00.000","Headline":"Online Extra: A \"Highly Focused\" Health Fund","Summary":"The Live Oak Health Sciences fund has delivered impressive returns by scouting both startups and giants for promising treatments"},{"Date":"2005-07-15T00:00:00.000","Headline":"Stocks End Slightly Higher","Summary":"Next week, Alan Greenspan gives his monetary policy testimony, while companies such as IBM, Intel, and Microsoft report earnings"},{"Date":"2005-07-21T00:00:00.000","Headline":"eBay Net Rises","Summary":"McDoanld's, Coca-Cola report higher profits; Take-Two game slapped with Adults Only rating; plus more of Thursday's stocks in the news"},{"Date":"2005-08-15T00:00:00.000","Headline":"Drugmakers Are Changing Channels","Summary":"All those Ask your doctor if it's right for you ads on TV haven't delivered"},{"Date":"2005-08-17T00:00:00.000","Headline":"Obscure Firms Are Among the 15 Most Profitable: John Dorfman","Summary":"Since 1998, well-known companies such as Microsoft Corp. (MSFT), Bristol-Myers Squibb Co. (BMY) and Oracle Corp. (ORCL) have starred in my annual list of the 15 most profitable companies in the U.S."},{"Date":"2005-08-23T00:00:00.000","Headline":"Amilyn Shares Surge","Summary":"La-Z-Boy results swing to profit; Pier 1 lower on sales shortfall; plus more of Tuesday's stocks in the news"},{"Date":"2005-09-01T00:00:00.000","Headline":"Aiming for Royal Returns","Summary":"S&P believes investing in stocks with consistently rising payouts is a sound strategy, so here's an updated list of dividend aristocrats"},{"Date":"2005-09-05T00:00:00.000","Headline":"Drugs Get Smart","Summary":"New medicines will more effectively target what ails you -- and help prevent another Vioxx"},{"Date":"2005-09-12T00:00:00.000","Headline":"Speed Bumps For Dealmakers","Summary":"Proposed rule changes may force buyers to bare more detail -- and take more lumps"},{"Date":"2005-10-03T00:00:00.000","Headline":"The Real Reasons You're Working So Hard...","Summary":"...and what you can do about it"},{"Date":"2005-10-17T00:00:00.000","Headline":"Prescription For Upheaval","Summary":"How the Medicare drug program is tightening the screws on Big Pharma"},{"Date":"2005-10-20T00:00:00.000","Headline":"Stocks Finish Sharply Lower","Summary":"Disappointing earnings news from Pfizer, eBay, and others pressured the major indexes"},{"Date":"2005-10-20T00:00:00.000","Headline":"Pfizer Sees Lower 2005 Revenue","Summary":"Ford, eBay and Coca-Cola also post quarterly results; plus more of Thursday's stocks in the news"},{"Date":"2005-10-24T00:00:00.000","Headline":"Online Extra: The Top 500","Summary":"Here's the full Europe's 500 list as compiled by Europe's Entrepreneurs for Growth"},{"Date":"2005-11-01T00:00:00.000","Headline":"A Cautious Bull Among the Bears","Summary":"Michael Farr of Farr, Miller & Washington is sanguine about the long-term market outlook and thinks tech is one sector poised to deliver"},{"Date":"2005-11-28T00:00:00.000","Headline":"My, How You've Grown","Summary":"A wave of drugs for short kids is sparking controversy -- and an expanding market"},{"Date":"2005-12-09T00:00:00.000","Headline":"Intel's Outlook Fails to Impress the Street","Summary":"Electronic Arts to acquire Jamdat Mobile, Valor plans to buy Alltel's wireline business, Paramount to bid for DreamWorks Animation, plus more stocks in the news Friday"},{"Date":"2005-12-09T00:00:00.000","Headline":"S&P Lowers Opinion of Credit Suisse Group's Stock","Summary":"Plus: analyst comments about Eli Lilly, Gateway, Alltel's wireline spinoff deal with Valor, Intel's guidance revision, and Merck's disagreement with a New England Journal of Medicine editorial that says the drug company withheld data about Vioxx."},{"Date":"2005-12-13T00:00:00.000","Headline":"S&P Boosts Lilly, Cuts Adobe","Summary":"Plus: Analysts downgrade CBRL Group, upgrade Kohl's, and comment on H-P's disappointing guidance"},{"Date":"2005-12-30T00:00:00.000","Headline":"Who's Who in PowerPicks 2006","Summary":"S&P's analysts exlain why they expect their favored stocks to perform strongly in the new year"},{"Date":"2005-12-30T00:00:00.000","Headline":"S&P's Top-Shelf Selections","Summary":"From the 1,500 stocks they cover, S&P analysts  have skimmed the cream for the PowerPicks Portfolio 2006"},{"Date":"2006-01-09T00:00:00.000","Headline":"Bucking The Odds at Amylin","Summary":"With Ginger Graham at the helm, the company has two approved diabetes drugs"},{"Date":"2006-01-09T00:00:00.000","Headline":"Businesses Must Learn to Let Go","Summary":"In a rapidly globalizing world, focusing on core expertise and collaborating with partners in innovative ways are the keys to growth"},{"Date":"2006-01-30T00:00:00.000","Headline":"The Future Of Outsourcing","Summary":"How it's transforming whole industries and changing the way we work"},{"Date":"2006-01-30T00:00:00.000","Headline":"Online Extra: Lilly's Labs Go Global","Summary":"To cut costs and speed development, the drugmaker steps up R&D outsourcing -- including clinical trials -- to countries such as India and China"},{"Date":"2006-02-06T00:00:00.000","Headline":"Online Extra: Bio: Robert Ruffolo","Summary":"BIRTH: April, 1950, in Yonkers, N.Y."},{"Date":"2006-02-15T00:00:00.000","Headline":"A Shot in the Arm for Pharma","Summary":"The sector's prospects are looking a good more positive, thanks to a healthier product pipeline and gains from the new Medicare drug benefit"},{"Date":"2006-02-17T00:00:00.000","Headline":"Seeding a Growth Portfolio","Summary":"As winter yields to spring, the market may be entering a season of outperformance for growth stocks"},{"Date":"2006-03-20T00:00:00.000","Headline":"Lilly Is Starting To Bloom","Summary":"Big pharma has been in the doldrums for years, ravaged by generic rivals, class actions, and trickling product pipelines. But some pockets are perking up. Eli Lilly (LLY"},{"Date":"2006-03-27T00:00:00.000","Headline":"Cortex Draws A Bead On Hyperactivity","Summary":"One condition Wall Street pays heed to is attention deficit hyperactivity disorder (ADHD), which affects 4 million children and 3 million adults in the U.S. When Cortex Pharmaceuticals (COR"},{"Date":"2006-03-28T00:00:00.000","Headline":"Stocks Fall as More Fed Hikes Loom","Summary":"The FOMC announced a quarter-point rate hike and hinted that further tightening may be necessary"},{"Date":"2006-04-03T00:00:00.000","Headline":"More Companies Agree To Disclose Donations","Summary":"Advocates for shareholders are making headway in their bid to prod companies to disclose soft-money political donations. Bristol-Myers Squibb (BMY) and Staples (SPLS) are the latest businesses to agree to reveal and give their boards oversight on soft money donations -- the large contributions that companies and individuals can make to state parties. In addition, Amgen's (AMGN) board has endorsed a shareholder resolution calling for oversight and disclosure. Shareholders will vote on the plan at"},{"Date":"2006-04-12T00:00:00.000","Headline":"Bausch & Lomb Shares Fall Further","Summary":"Harley-Davidson shares fall; Danaher to buy Sybron Dental; plus more stocks in the news Wednesday"},{"Date":"2006-04-17T00:00:00.000","Headline":"Big Pharma Wants More Time","Summary":"Expect a new skirmish between Big Pharma and the generics. Some leading drugmakers are preparing a push for legal changes to extend their period of protection from generic rivals. Industry executives say that Bristol-Myers Squibb (BMY) CEO Peter Dolan, who now heads the Pharmaceutical Research & Manufacturers of America, an industry association, is likely to make the effort a top priority. A drug's patent protection typically lasts about 20 years. But it runs from the time a compound is disc"},{"Date":"2006-04-17T00:00:00.000","Headline":"\"The Pit Bull Of Public Relations\"","Summary":"Eric Dezenhall serves clients such as ExxonMobil by going after their foes"},{"Date":"2006-04-18T00:00:00.000","Headline":"Lilly's Breast-Cancer Breakthrough","Summary":"Released on Apr. 17, the results of a massive clinical trial for prevention of breast cancer contained mostly good news"},{"Date":"2006-05-04T00:00:00.000","Headline":"A Better Prognosis for Big Pharma","Summary":"Concerns remain, but new products, improving R&D, and the continued validity of major patents may have eased the industry's ratings slide"},{"Date":"2006-05-22T00:00:00.000","Headline":"Lilly Loses One","Summary":"Big Pharma may need to pop some Prozac after this. On May 4 a Boston jury ruled that Eli Lilly (LLY) must pay $65.2 million in royalties to Ariad Pharmaceuticals (ARIA), a biotech outfit that has licensed the patent to a cellular process in the body triggered by a major protein. Lilly's osteoporosis drug Evista and its septic-shock medication Xigris trigger the same process. Lilly vows an appeal, contending Ariad's patent is almost as broad as claiming the rights to gravity. The drugmaker has at"},{"Date":"2006-06-12T00:00:00.000","Headline":"Big Pharma's Nurse Will See You Now","Summary":"Drug companies are hiring RNs to educate patients -- and boost marketing"},{"Date":"2006-07-03T00:00:00.000","Headline":"A Ton Of Prevention","Summary":"The pros and cons of two drugs that may halve your risk of breast cancer"},{"Date":"2006-07-17T00:00:00.000","Headline":"A Key New Ally In The Cancer War","Summary":"China gets help from the West -- and both gain"},{"Date":"2006-07-21T00:00:00.000","Headline":"Dell Sees Lower Earnings Than Forecast","Summary":"Microsoft plans to buy back stock; Google's results are stronger; AMD sales fall short of estimates; plus more stocks in the news Friday"},{"Date":"2006-08-07T00:00:00.000","Headline":"Big Pharma's Big Numbers","Summary":"Big-name drugs don't just help patients; they've taken the pharmaceutical sector off its sickbed, too. Merck (MRK) and Schering-Plough (SGP) emerged on July 24 as two of the most prominent winners. Both enjoyed soaring demand for cholesterol-lowering drugs, including Zetia and Vytorin, which they market through a joint venture. Glaxo (GSK), Eli Lilly (LLY), and Wyeth (WYE) also posted higher earnings. Big Pharma is profiting from the new Medicare Part D drug benefit, which has fueled an increase"},{"Date":"2006-09-01T00:00:00.000","Headline":"Bipolar Disorder Takes a Toll","Summary":"A new study details the costs of manic depression in the workplace, but more information is needed to determine a thoughtful response"},{"Date":"2006-09-12T00:00:00.000","Headline":"Shakeup Stirs Bristol-Myers Shares","Summary":"The stock climbed Tuesday after the company announced the exit of chief executive Peter Dolan"},{"Date":"2006-09-18T00:00:00.000","Headline":"The Best Places To Launch A Career","Summary":"The top 50 employers for new college grads"},{"Date":"2006-09-25T00:00:00.000","Headline":"Crowdsourcing","Summary":"Milk the masses for inspiration"},{"Date":"2006-10-09T00:00:00.000","Headline":"An ETF For Every Nest","Summary":"Even with product overload, investors are finding smart ways to use these index-based funds"},{"Date":"2006-10-16T00:00:00.000","Headline":"Still Working And Loving It","Summary":"With retiring boomers expected to cause a shortage of skilled staff, employers are making it easier for them to stay"},{"Date":"2006-10-19T00:00:00.000","Headline":"S&P Cuts Lilly to Hold","Summary":"Plus: Analyst opinions on Bank of America, Juniper Networks, and more"},{"Date":"2006-10-25T00:00:00.000","Headline":"Yankee Candle Agrees to a Buyout","Summary":"Universal American Financial gets a buyout proposal from management, and more deal news"},{"Date":"2006-11-09T00:00:00.000","Headline":"Showdown with Big Pharma","Summary":"Investors are jittery about the incoming House Democratic majority's plans to challenge drugmakers on pricing"},{"Date":"2006-12-07T00:00:00.000","Headline":"Home Depot Finds $200 Million of Option Errors","Summary":"Eli Lilly and Hershey give guidance; plus more stocks in the news Thursday"},{"Date":"2006-12-07T00:00:00.000","Headline":"Vanda: Tiny Pharma, Big Opportunity?","Summary":"The shares soared Thursday after a positive trial for a drug that could help the company crack the $10 billion schizophrenia market"},{"Date":"2006-12-18T00:00:00.000","Headline":"Bitter Pills","Summary":"More and more people are buying prescription drugs from shady online marketers. That could be hazardous to their health"},{"Date":"2006-12-18T00:00:00.000","Headline":"Express Scripts Bids to Buy Caremark for $26 Billion","Summary":"Harrah's reportedly to accept offer from investment group; private equity group to buy Biomet; plus more stocks in the news Monday"},{"Date":"2006-12-18T00:00:00.000","Headline":"S&P Cuts L3 Communications to Hold","Summary":"Plus: Analyst opinions on Realogy, Directed Electronics, and more"},{"Date":"2006-12-26T00:00:00.000","Headline":"Stocks Rise as Oil Prices Fall","Summary":"Crude futures tumbled below $61 on warmer weather forecasts, while an early report projected disappointing holiday retail sales"},{"Date":"2006-12-26T00:00:00.000","Headline":"Nacco Industries Raises Offer for Applica","Summary":"BB&T agrees to acquire Coastal Financial, and more deal news"},{"Date":"2006-12-27T00:00:00.000","Headline":"Dow Tops 12,500 after Upbeat Housing Data","Summary":"The blue-chip benchmark reached another all-time closing high. November new home sales bounced 3.4%, while crude futures fell below $61"},{"Date":"2007-01-04T00:00:00.000","Headline":"Lilly Gets a Lift from Zyprexa News","Summary":"The drugmaker expects to pay less than $500 million to settle lawsuits connected with the anti-psychotic compound"},{"Date":"2007-01-04T00:00:00.000","Headline":"Falling Oil Lifts Stocks","Summary":"Crude futures slid below $56 after a bearish inventory report. But retailers' December sales results disappointed the Street"},{"Date":"2007-01-08T00:00:00.000","Headline":"Decoding Alzheimer's","Summary":"After a century, promising treatments at lastand whispers of a cure"},{"Date":"2007-01-18T00:00:00.000","Headline":"A Diagnostics Deal for GE and Abbott","Summary":"CEO Miles White fuels his M&A streak with an agreement to sell two-thirds of Abbott's diagnostics business to GE for $8.1 billion in cash"},{"Date":"2007-01-29T00:00:00.000","Headline":"Abbot Labs: Diagnosis: Shrewd Moves","Summary":"Over the last nine months, Abbott Laboratories (ABT"},{"Date":"2007-01-31T00:00:00.000","Headline":"Boeing Posts Higher Earnings","Summary":"Bausch & Lomb sees lower sales in 2006; Allstate reports higher net; plus more stocks in the news Wednesday"},{"Date":"2007-02-05T00:00:00.000","Headline":"The Doctor Won't See You Now","Summary":"Dr. Lucy E. Hornstein is fed up with pharmaceutical salespeople. So whenever a rep walks into her Valley Forge (Pa.) family practice, she whips out a sheet of rules. Among them: No visits allowed except between noon and 2 p.m. Do not bring any pens, sticky pads, or other knickknacks bearing the name of the drug you're touting. Furthermore, Hornstein says, \"I tell them, 'don't talk to me about drugs because everything you say is propaganda.'\" The constant stream of salespeople in Hornstein's offi"},{"Date":"2007-02-15T00:00:00.000","Headline":"Ideagora, a Marketplace for Minds","Summary":"Ideas and innovations are increasingly coming from outside company wallsand Web-based virtual talent pools are stepping in to fill the need"},{"Date":"2007-02-26T00:00:00.000","Headline":"Pushing The Pills A Bit Too Hard","Summary":"Feds and states are putting drug marketing under the microscope and seeing abuse"},{"Date":"2007-03-12T00:00:00.000","Headline":"Charging The Batteries At Altair","Summary":"Altair nanotechnologies (ALTI"},{"Date":"2007-03-12T00:00:00.000","Headline":"Schering's Risky Growth Gambit","Summary":"The pharma's $14.4 billion deal to buy Organon BioSciences represents a big bet on the tricky schizophrenia-drug market"},{"Date":"2007-04-09T00:00:00.000","Headline":"Taming the World Wide Web","Summary":"A rising tide of companies are tapping Semantic Web technologies to unearth hard-to-find connections between disparate pieces of online data"},{"Date":"2007-04-16T00:00:00.000","Headline":"Stocks Jump on Deals, Retail Sales","Summary":"Takeover news and a strong reading on retail sales, plus earnings from Citigroup lured buyers. Up next: CPI, housing starts, industrial production"},{"Date":"2007-04-16T00:00:00.000","Headline":"Looking Into Pharma's Profit Pipeline","Summary":"If Merck is any indication, first-quarter earnings of major players could be just what the doctor ordered. The longer term is another story"},{"Date":"2007-04-16T00:00:00.000","Headline":"Big Pharma's Animal Spirits","Summary":"Sales of medicine for pets and livestock  are giving drugmakers a welcome boost"},{"Date":"2007-04-16T00:00:00.000","Headline":"Investors to Buy Sallie Mae for $25 Billion","Summary":"Fremont General to sell subprime loans and residential real estate business; plus more stocks in the news Monday"},{"Date":"2007-05-25T00:00:00.000","Headline":"Coca-Cola Acquires Energy Brands","Summary":"Nasdaq says it plans to acquire OMX AB in a $3.7 billion deal, and more stocks in the news"},{"Date":"2007-05-28T00:00:00.000","Headline":"The Rush To Test Drugs In China","Summary":"Despite ethical concerns, Big Pharma is recruiting more patients for clinical trials"},{"Date":"2007-06-12T00:00:00.000","Headline":"NineSigma: Nurturing 'Open Innovation'","Summary":"Sometimes a company has to go outside its R&D department and tap outside experts. NineSigma CEO Paul Stiros describes how it works"},{"Date":"2007-06-13T00:00:00.000","Headline":"Is Europe's Health Care Better?","Summary":"U.S. health care has been declared a disaster. Britain's subsidized NHS is little better. France's hybrid system works, but faces rising costs"},{"Date":"2007-06-15T00:00:00.000","Headline":"Are Pharmas Addicted to Lifestyle Drugs?","Summary":"Drugmakers are eager to spiff up your sex life and hairline, even as their lucrative products face mounting safety questions"},{"Date":"2007-07-02T00:00:00.000","Headline":"Lifestyle Drug Binge","Summary":"The huge profits in weight-loss and other treatments makes them hard for drugmakers to resist. But safety risks abound"},{"Date":"2007-07-09T00:00:00.000","Headline":"The Search for Angiogenesis Therapy","Summary":"The race is on to win FDA approval for a treatment that enables the human body to grow new blood vessels"},{"Date":"2007-07-16T00:00:00.000","Headline":"The Good and Bad of Tagalong Technology","Summary":"Companies large and small are seeing their proprietary information compromised by employees' personal devices, and they're taking action"},{"Date":"2007-07-24T00:00:00.000","Headline":"Movers: AT&T, Texas Instruments, Countrywide Financial","Summary":"Tuesday's stocks in the news"},{"Date":"2007-07-25T00:00:00.000","Headline":"Stocks Rocked by Earnings, Debt Worries","Summary":"Disappointing quarterly profits were compounded by fears about the spreading subprime crisis. The S&P 500 tumbled almost 2%"},{"Date":"2007-07-26T00:00:00.000","Headline":"Battle for the Future of the Net","Summary":"The Semantic Web connects information in novel ways. Will EU tech companies drop the ball on another breakthrough?"},{"Date":"2007-08-01T00:00:00.000","Headline":"Avandia Clears a Hurdle","Summary":"An FDA advisory panel is recommending that GlaxoSmithKline's controversial diabetes drug remain on the U.S. market. Can it recover its lost share?"},{"Date":"2007-08-06T00:00:00.000","Headline":"The Pet Economy","Summary":"Americans spend an astonishing $41 billion a year on their furry friends"},{"Date":"2007-08-13T00:00:00.000","Headline":"Online Extra: Gene Marcial's Annual Report Card","Summary":"Below are the 151 stocks featured in the column last year along with their one-day, one-month, three-month, and six-month percentage returns. *"},{"Date":"2007-08-20T00:00:00.000","Headline":"Profiting from Fake Pharma","Summary":"Online sellers of counterfeit versions of several name-brand drugs generate more than $4 billion a year, according to a new study"},{"Date":"2007-09-14T00:00:00.000","Headline":"Movers: Hovnanian, American Express, Monsanto, Tween Brands","Summary":"Friday's stocks in the news"},{"Date":"2007-09-17T00:00:00.000","Headline":"Stocks Squeeze Out Small Gains","Summary":"Traders weighed mixed economic data and news of credit troubles at a British mortgage lender. Next week's big event: The FOMC meeting Tuesday"},{"Date":"2007-09-24T00:00:00.000","Headline":"Big Pharma Targets Alzheimer's","Summary":"This degenerative brain disease will claim even more victims in the coming decades. Drug companies are racing to improve treatments and find a vaccine"},{"Date":"2007-10-18T00:00:00.000","Headline":"Movers: Google, Bank of America, Washington Mutual, Pfizer, Nokia, eBay","Summary":"Thursday's stocks in the news"},{"Date":"2007-10-25T00:00:00.000","Headline":"Movers: Microsoft, VMware, EMC, Motorola, Bristol-Myers Squibb","Summary":"Thursday's stocks in the news"},{"Date":"2007-11-05T00:00:00.000","Headline":"Ballard Power, Home Depot, Merrill Lynch: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in U.S. exchanges. This preview includes news that broke after exchanges closed. Stock symbols are in parentheses after company names. Share prices are as of 7:30 a.m. in New York."},{"Date":"2007-11-19T00:00:00.000","Headline":"Ceragon, China Sunergy, EchoStar, Xerox: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes on U.S. exchanges tomorrow. Stock symbols are in parentheses after company names and prices are as of 8:55 a.m. in New York."},{"Date":"2007-12-06T00:00:00.000","Headline":"BioCryst, Lilly, En Pointe, Hoku, Methode: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in U.S. exchanges today. Stock symbols are in parentheses after company names. Share prices are as of 8:40 a.m. in New York."},{"Date":"2007-12-17T00:00:00.000","Headline":"Adobe, Eli Lilly, Range Resources, Trump: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in U.S. exchanges tomorrow. Stock symbols are in parentheses after company names."},{"Date":"2007-12-18T00:00:00.000","Headline":"Best Buy, Eli Lilly, Goldman Sachs, Sprint: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in U.S. exchanges today. Stock symbols are in parentheses after company names. Share prices are as of 8:30 a.m. in New York."},{"Date":"2007-12-20T00:00:00.000","Headline":"Executive Suite","Summary":"Sprint Nextel (S) on Dec. 18 named a new go-to guy: Daniel Hesse, who headed the company's local phone spin-off, Embarq. He replaces Gary Forsee, ousted as CEO in October. The new chief will have his handset full trying to regain lost market share and deciding whether to continue initiatives such as Sprint's wireless broadband rollout. Also on Dec. 18, Eli Lilly (LLY) said President John Lechleiter will succeed retiring CEO Sidney Taurel in March."},{"Date":"2008-01-02T00:00:00.000","Headline":"Launching from London","Summary":"About 70% of LBS grads go into finance or consulting. The school's director of career services talks about how LBS can help its job seekers"},{"Date":"2008-01-07T00:00:00.000","Headline":"Movers: SLM, Network Appliance, Alcoa, Best Buy, Shoretel","Summary":"Monday's stocks in the news"},{"Date":"2008-01-17T00:00:00.000","Headline":"Stocks Go From Bad to Horrible","Summary":"The Dow tumbled over 300 points Thursday amid huge losses at Merrill Lynch and gloomy testimony from Bernanke"},{"Date":"2008-01-17T00:00:00.000","Headline":"Movers: Ambac, Merrill Lynch, Callaway Golf, Bank of New York","Summary":"Thursday's stocks in the news"},{"Date":"2008-01-28T00:00:00.000","Headline":"A Pivotal Week for Stocks","Summary":"Data and earnings releases -- and the Fed meeting -- may offer a clearer view of the market landscape. Investors may not like what they see"},{"Date":"2008-01-29T00:00:00.000","Headline":"Movers: Yahoo, VMware, EMC, American Express, IAC\/InterActiveCorp","Summary":"Tuesday's stocks in the news"},{"Date":"2008-01-29T00:00:00.000","Headline":"Stocks End Higher","Summary":"Investors eyed surprisingly strong durable goods report and a sharp drop in U.S. home prices, as the Federal Reserve pondered another interest rate cut"},{"Date":"2008-01-31T00:00:00.000","Headline":"Bones of Contention","Summary":"Drugmakers are stoking fears of fracture among middle-aged women. But experts say the risk is low"},{"Date":"2008-02-07T00:00:00.000","Headline":"Why Cypress Is Feeling No Pain","Summary":"Several hedge funds focused on biotechs are buying into Cypress Bioscience (CYPB). Why? Its product, Milnacipran, a treatment for fibromyalgia, now in Phase III clinical trials, has a potential U.S. market of $1 billion, analysts say. Some 6 million Americans suffer from fibromyalgia\u2014muscle and joint pain, fatigue, depression, and sleeplessness. Cypress and partner Forest Laboratories (FRX) have filed a new drug application with the Food & Drug Administration. Pfizer (PFE) has a similar drug"},{"Date":"2008-02-14T00:00:00.000","Headline":"The Drugmaker's Friend: Pharsight","Summary":"Little-known Pharsight (PHST) provides services to Big Pharma, including Pfizer (PFE) and Eli Lilly (LLY)--plus the Food & Drug Administration. Using its simulation software, Pharsight helps drugmakers and biotechs decide whether to put a new compound through expensive clinical trials. \"We help save hundreds of millions of dollars,\" says CEO Shawn O'Connor. The FDA is using Pharsight's tools to standardize its own analysis of drugs. Pfizer employed one of Pharsight's software programs early"},{"Date":"2008-02-22T00:00:00.000","Headline":"ArcelorMittal, Cbeyond, Intuit, LDK Solar: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in U.S. markets today. Stock symbols are in parentheses after company names, and prices are as of 7:17 a.m. in New York."},{"Date":"2008-02-22T00:00:00.000","Headline":"ATS Medical, Fannie Mae, Lloyds, Nicor: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in U.S. markets today. Stock symbols are in parentheses after company names, and prices are as of 8:33 a.m. in New York."},{"Date":"2008-02-22T00:00:00.000","Headline":"Force Protection, Life Time, Orthofix, The9: U.S. Equity Movers","Summary":"The following is a list of companies whose shares are having unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 10:10 a.m. in New York."},{"Date":"2008-02-22T00:00:00.000","Headline":"S&P Picks and Pans: MBIA, Intuit, Lilly, Brown-Forman, Teva","Summary":"Analyst opinions on stocks making headlines in Friday's market"},{"Date":"2008-02-28T00:00:00.000","Headline":"Movers: Sprint Nextel, MF Global, Freddie Mac, Thornburg Mortgage","Summary":"Thursday's stocks in the news"},{"Date":"2008-03-06T00:00:00.000","Headline":"Take Two of These, and Go to the Gym","Summary":"A new class of drugs could significantly increase the benefits of an overall weight-loss regime. But first, drugmakers have to prove they're safe"},{"Date":"2008-03-06T00:00:00.000","Headline":"Inside Drugmakers' War on Fat","Summary":"A huge jackpot awaits the company that devises an effective fix for obesity"},{"Date":"2008-03-07T00:00:00.000","Headline":"CRA, Eli Lilly, MBIA, United Technologies: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in U.S. markets on March 10. Stock symbols are in parentheses after company names."},{"Date":"2008-03-10T00:00:00.000","Headline":"Movers: Citigroup, Bear Stearns, MBIA, Countrywide, Virgin Media, Fannie Mae","Summary":"Monday's stocks in the news"},{"Date":"2008-03-13T00:00:00.000","Headline":"Diamonds North, Toronto-Dominion Bank: Canada Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Canada. Stock symbols are in parentheses after company names, and prices are as of the last close in Toronto"},{"Date":"2008-03-17T00:00:00.000","Headline":"Test Time for India's Drugmakers","Summary":"India's pharma companies are moving beyond generics to set their sights on the research and development of new drugs, but the risks are many"},{"Date":"2008-03-20T00:00:00.000","Headline":"What Ever Happened to 'An Apple a Day'?","Summary":"Making the case that Big Pharma is obsessed with saleseven at the risk of patients' health"},{"Date":"2008-04-17T00:00:00.000","Headline":"Calendar","Summary":"Calendar"},{"Date":"2008-04-18T00:00:00.000","Headline":"Stocks: The Kings of Cash","Summary":"S&P tracks down the blue chip names with the biggest cash stockpilesand the top ratings from its equity analysts"},{"Date":"2008-04-21T00:00:00.000","Headline":"Aladdin, Sears Holdings, Sovereign Bancorp: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. trading. Stock symbols are in parentheses, and share prices are as of 1:10 p.m. in New York."},{"Date":"2008-04-21T00:00:00.000","Headline":"S&P Picks and Pans: Bank of America, National City, Mattel, Hasbro, Merck, Eli Lilly","Summary":"Analysts' opinions on stocks in the news Monday"},{"Date":"2008-04-21T00:00:00.000","Headline":"Movers: Bank of America, National City, Apple, Merck, Eli Lilly, Mattel, Hasbro","Summary":"Monday's stocks in the news"},{"Date":"2008-04-21T00:00:00.000","Headline":"Stocks Finish Mixed","Summary":"Bank of America's first quarter earnings disappointed Wall Street, while National City slashed its dividend. Oil prices closed above $117, a new record"},{"Date":"2008-04-22T00:00:00.000","Headline":"Biotech Isn't in the DNA","Summary":"Despite Chicago's efforts to foster a local life-science community, the metro area trails second-tier genetics centersand is way behind the leaders"},{"Date":"2008-05-07T00:00:00.000","Headline":"Is U.S. Innovation Headed Offshore?","Summary":"Apparently not, even though more research and development is joining manufacturing in the shift toward low-cost nations"},{"Date":"2008-05-16T00:00:00.000","Headline":"Cancer Research Group Releases Data","Summary":"To curtail data leaks that can affect drugmakers' stock prices, the American Society of Clinical Oncology discloses trial outcomes before its annual meeting"},{"Date":"2008-05-16T00:00:00.000","Headline":"Stocks Finish Mixed amid Oil Surge","Summary":"A late burst of buying Friday helped the market trim earlier, steeper losses despite a jump in crude prices"},{"Date":"2008-05-23T00:00:00.000","Headline":"Anheuser-Busch, CA, Hibbett Sports, Zumiez: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 9:40 a.m. in New York."},{"Date":"2008-05-23T00:00:00.000","Headline":"Cheesecake Factory, Pacific Sunwear, Verigy: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 10:10 a.m. in New York."},{"Date":"2008-06-01T00:00:00.000","Headline":"Eastman Kodak, Eaton, Genentech, ImClone: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. trading tomorrow. Stock symbols are in parentheses, and share prices are from the previous close unless stated otherwise."},{"Date":"2008-06-02T00:00:00.000","Headline":"Acorda, Delta, Eaton, Harris, Infineon: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 8 a.m. unless stated otherwise."},{"Date":"2008-06-02T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2008-06-02T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2008-06-10T00:00:00.000","Headline":"Losing Our Lead in Innovative R&D","Summary":"A new Duke and Harvard study shows that research in China and India is getting more sophisticated much faster than the numbers let on"},{"Date":"2008-06-24T00:00:00.000","Headline":"Movers: UBS, UPS, Kodak, ComScore, Kroger, ConAgra, Dow Chemical","Summary":"Stocks in the news on Tuesday"},{"Date":"2008-06-26T00:00:00.000","Headline":"Drugmakers and College Labs: Too Cozy?","Summary":"Medical researchers at Harvard and Stanford have failed to disclose millions in payments from Big Pharma, an Iowa senator charges"},{"Date":"2008-07-09T00:00:00.000","Headline":"Movers: Alcoa, Cisco Systems, Merrill Lynch, Freddie Mac, Fannie Mae, QLogic","Summary":"Stocks in the news on Wednesday"},{"Date":"2008-07-25T00:00:00.000","Headline":"The Implications of Health-Care Reform","Summary":"The U.S. health-care system faces many problems, which are widely publicized: the stress of an aging population and rising costs, tremendous inefficiencies, and imperfect quality"},{"Date":"2008-07-31T00:00:00.000","Headline":"Alzheimer's Drugs: Investors' Impatience","Summary":"Mixed drug trial results at the International Conference on Alzheimer's Disease deflate Wall Street, but scientists remain hopeful"},{"Date":"2008-08-04T00:00:00.000","Headline":"Marcial: Clinical Data Is a Biotech to Watch","Summary":"Activist investor Randal Kirk, who knows from companies that have attracted the eye of Big Pharma, finds the company's new antidepressant, Vilazodone, a reason to feel better"},{"Date":"2008-08-11T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2008-08-18T00:00:00.000","Headline":"Amylin, First Marblehead, Hershey, SanDisk: U.S. Equity Movers","Summary":"The following companies had unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 4 p.m. in New York."},{"Date":"2008-08-27T00:00:00.000","Headline":"Movers: Fannie Mae, Freddie Mac, Lehman, Amylin, Dollar Tree, J.Crew","Summary":"Stocks in the news Wednesday"},{"Date":"2008-08-27T00:00:00.000","Headline":"Ikon, Quiksilver, TomoTherapy: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. markets. Stock symbols are in parentheses, and prices are as of 2:20 p.m. in New York."},{"Date":"2008-08-27T00:00:00.000","Headline":"Amylin, Borders, Cell Genesys, Ikon, Tesoro: U.S. Equity Movers","Summary":"The following companies had unusual price changes in U.S. markets. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York."},{"Date":"2008-08-27T00:00:00.000","Headline":"AMR, Amylin, J.Crew, SI International, UAL: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. markets. Stock symbols are in parentheses, and prices are as of 9:40 a.m. in New York."},{"Date":"2008-08-27T00:00:00.000","Headline":"Aflac, Amylin, J. Crew, Mattel, Merrill: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 8 a.m. in New York, unless stated otherwise."},{"Date":"2008-08-27T00:00:00.000","Headline":"Amylin, Frontier Oil, J.Crew, Stoneridge: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. markets. Stock symbols are in parentheses, and prices are as of 1:05 p.m. in New York."},{"Date":"2008-09-04T00:00:00.000","Headline":"Chinese Scientists Build Big Pharma Back Home","Summary":"In a reverse migration, U.S.-trained scientists are setting up biotech startups, contract-research companies, and university labs on the mainland"},{"Date":"2008-09-04T00:00:00.000","Headline":"Outsourcing the Drug Industry","Summary":"U.S. giants are rushing to partner with Indian and Chinese companiestapping their brainpower and saving millions of dollars in the search for breakthrough treatments"},{"Date":"2008-09-04T00:00:00.000","Headline":"Chasing Blockbuster Drugs, Using Chinese Help","Summary":"Small biotech Curis couldn't afford to develop entirely new drugs in the U.S. So like many others, it outsourced its R&D to China"},{"Date":"2008-09-12T00:00:00.000","Headline":"Pfizer's New Rx","Summary":"Big Pharma continued its makeover this week. On Sept. 30, Pfizer (PFE) said it will end its research into heart disease, long the drugmaker's biggest market, in favor of cancer, Alzheimer's, and diabetes, and will sell or share the rights to 11 pipeline drugs the company no longer thinks will bring in enough money. GlaxoSmithKline (GSK) will lay off as many as 850 research staffers in a bid to boost productivity. And on Oct. 1, The Wall Street Journal reported that Eli Lilly (LLY) is ImClone Sys"},{"Date":"2008-09-19T00:00:00.000","Headline":"The Global Talent Crisis","Summary":"In today's complex environment, a strategy for attracting skilled people is as critical as a marketing or finance strategy"},{"Date":"2008-09-29T00:00:00.000","Headline":"Movers: Wachovia, Citigroup, Pilgrim's Pride, Apple","Summary":"Stocks in the news Monday"},{"Date":"2008-10-01T00:00:00.000","Headline":"Movers: GE, ImClone Systems, Ford, AIG, Boston Scientific","Summary":"Stocks in the news Wednesday"},{"Date":"2008-10-02T00:00:00.000","Headline":"S&P Picks and Pans: GE, UBS, Micron, Eli Lilly","Summary":"Analysts' opinions on stocks in the news Thursday"},{"Date":"2008-10-02T00:00:00.000","Headline":"Barbera Bargains","Summary":"Wines produced from Northern Italy's barbera grape are well made and surprisingly well priced"},{"Date":"2008-10-03T00:00:00.000","Headline":"Why All the ImClone Interest? Its Pipeline","Summary":"Eli Lilly, hungry to bulk up in better-protected oncology drugs, outbid Bristol-Myers Squibb for Carl Icahn's hot property"},{"Date":"2008-10-06T00:00:00.000","Headline":"Dow Drops 370 Points","Summary":"The blue chip index sank below 10,000 amid deepening worries about the financial crisis. Markets in Europe and Asia also tumbled"},{"Date":"2008-10-06T00:00:00.000","Headline":"Movers: Wells Fargo, Wachovia, Citigroup, ImClone, eBay","Summary":"Stocks in the news Monday"},{"Date":"2008-10-06T00:00:00.000","Headline":"S&P Picks and Pans: Citigroup, Wells Fargo, ImClone, Royal Bank of Scotland, AMB Property","Summary":"Analysts' opinions on stocks in the news Monday"},{"Date":"2008-10-06T00:00:00.000","Headline":"EBay, Goldcorp, Hartford Financial, Salix: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 8:40 a.m. in New York."},{"Date":"2008-10-06T00:00:00.000","Headline":"Agfeed, EBay, Hartford, Research in Motion: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 8 a.m. in New York, unless otherwise specified."},{"Date":"2008-10-06T00:00:00.000","Headline":"Barclays, Goldcorp, AIG, Coke, ImClone: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 7:30 a.m. in New York, unless otherwise specified."},{"Date":"2008-10-06T00:00:00.000","Headline":"First Solar, Garmin, Home Depot, Wavecom: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. trading. Stock symbols are in parentheses, and share prices are as of 2:30 p.m. in New York."},{"Date":"2008-10-09T00:00:00.000","Headline":"Big Pharma Embraces the Contentious Cancer Business","Summary":"Short of blockbuster drugs, Eli Lilly is acquiring ImClone Systems' cancer drug pipeline. But governments want to control drug prices"},{"Date":"2008-10-09T00:00:00.000","Headline":"Score One for Icahn","Summary":"We won't have ImClone to kick around much longer. As rumored last week, Eli Lilly (LLY) proved to be the mystery suitor cited by Imclone Chairman Carl Icahn in spurning Bristol- Myers Squibb's (BMY) $62-a-share bid. Lilly agreed on Oct. 6 to buy the biotech for $65 million, or $70 a share, a 50% bump over the price in July before Bristol's offer. ImClone's only product on the market is cancer drug Erbitux, but Lilly mostly wants the pipeline. Imclone will forever be linked to the insider-trading"},{"Date":"2008-10-09T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2008-10-23T00:00:00.000","Headline":"Movers: Amazon, Amgen. Allstate, Altria, Dow Chemical, UPS","Summary":"Plus more stocks making headlines in Thursday's market"},{"Date":"2008-10-23T00:00:00.000","Headline":"Stocks Finish Mixed","Summary":"The Dow and S&P 500 posted gains while the Nasdaq dipped Thursday as investors hunted for bargains in beaten-down shares"},{"Date":"2008-10-30T00:00:00.000","Headline":"Four New Pharmaceutical Chief Executives Speak Out","Summary":"The CEOs of Pfizer, Roche, Eli Lilly, and Bristol-Myers Squibb address topics from dealmaking to the pharmaceutical industry's image problems"},{"Date":"2008-10-30T00:00:00.000","Headline":"Is Bristol Ripe for a Buyout?","Summary":"With the fundamentals improving at Bristol-Myers Squibb (BMY) and the stock spiraling down, the global drugmaker could be an enticing buyout target. Indeed, the company's huge sales, its array of products under development, and the shares' tumble to 19.78 on Oct. 29, down from 30 a year ago, make Bristol an \"attractive takeover candidate\" for drug giants (page 44) like Pfizer (PFE) or Sanofi-Aventis (SNY), says Jason Napolitano of Zacks Investment Research. French drugmaker Sanofi is Bristol's j"},{"Date":"2008-11-17T00:00:00.000","Headline":"General Motors, Goldman, Lowe's, Nokia: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 8 a.m. in New York, unless otherwise specified."},{"Date":"2008-11-17T00:00:00.000","Headline":"Alcoa, Citigroup, Las Vegas Sands, Target: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 9 a.m. in New York, unless otherwise specified."},{"Date":"2008-11-24T00:00:00.000","Headline":"Citigroup, JPMorgan, Omrix, SAIC, Target: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 8 a.m. in New York, unless otherwise specified."},{"Date":"2008-11-28T00:00:00.000","Headline":"Movers: Eli Lilly, STMicro, Panasonic, Watson Pharma","Summary":"Plus more stocks making headlines in Friday's market"},{"Date":"2008-12-04T00:00:00.000","Headline":"Barbaresco: Northern Italian Beauties","Summary":"Like Ferraris, Barbarescos are from Northern Italy, elegant, very expensive, and almost always worth it"},{"Date":"2008-12-11T00:00:00.000","Headline":"Movers: BCE, Sprint, Cadence Design, Ciena, Eli Lilly","Summary":"Stocks in the news Thursday"},{"Date":"2008-12-11T00:00:00.000","Headline":"S&P Picks and Pans: BCE, Cadence, Stanley Works, Ciena, Eli Lilly, Baidu.com","Summary":"Anaylsts' opinions on stocks in the news Thursday"},{"Date":"2009-01-08T00:00:00.000","Headline":"Stocks End Mixed Ahead of Jobs Report","Summary":"Traders anticipate another dismal showing for the labor market in Friday's report"},{"Date":"2009-01-15T00:00:00.000","Headline":"Movers: JPMorgan, Bank of America, Apple, Motorola, Microsoft","Summary":"JPMorgan Chase & Co. (JPM) posts $0.07, vs. $0.86 a year ago, fourth quarter EPS on 1% revenue drop. Notes $4.1 billion (pretax) increase to loan loss reserves in fourth quarter, $2.9 billion (pretax) net markdowns due to leveraged lending exposures and mortgage-related positions in the Investment Bank. Says if economy deteriorates further, which is a distinct possibility, it is reasonable to expect additional negative impact on its market-related businesses, continued higher loan losses and"},{"Date":"2009-01-15T00:00:00.000","Headline":"Stocks Finish Higher","Summary":"U.S. stocks finished in positive territory Thursday after being in the red for much of the session. A drop in the Dow industrials below 8,000 appeared to lure buyers into the market."},{"Date":"2009-01-27T00:00:00.000","Headline":"Soaring Cancer Drug Costs May Cripple Medicare","Summary":"Medicare spending on cancer drugs has skyrocketed in recent years, and Congress has severely limited the program's ability to do anything about it, says a report in the Feb. 7 issue of The New England Journal of Medicine."},{"Date":"2009-01-29T00:00:00.000","Headline":"Movers: Ford, Qualcomm, Dell, Black & Decker, Oshkosh","Summary":"Ford Motor (F) posts $1.37 fourth quarter loss from continuing operations (excluding special items), vs. $0.23 loss, on 36% revenue decline. Says, based on current planning assumptions, it does not need a bridge loan from the U.S. government, barring a significantly deeper economic downturn or a significant industry event. Also says it remains on track for both its overall, North American Automotive pre-tax results to be breakeven or profitable in 2011, excluding special items, based on current"},{"Date":"2009-01-29T00:00:00.000","Headline":"Stocks Slammed by Weak Data","Summary":"Financial markets' tentative optimism ahead of the passage of a U.S. stimulus plan -- which helped fuel a four-day advance for major equity indexes -- was swept aside Thursday by another grim round of economic reports. The worse than expected data on new home sales, durable goods orders, and weekly first-time jobless claims sent U.S. stock indexes sharply lower."},{"Date":"2009-02-04T00:00:00.000","Headline":"Biotech Stocks: Survival of the Fittest","Summary":"For years, large biotech companies could go about their business, safe in the knowledge that drug industry heavyweights would look to snap up smaller biotech players to plug the holes in their product pipelines. No longer. Roche (RO.DE) changed the game with its unsolicited bid for Genentech (DNA); on Jan. 30 the pharma giant offered to pay $86.50 a share for the 44% of the biotech it didn't already own. That announcement came on the heels of the Jan. 26 deal by Pfizer (PFE) to buy Wyeth (WYE)\u2014t"},{"Date":"2009-02-05T00:00:00.000","Headline":"Are Dividends in Dire Straits?","Summary":"Companies continue to slash dividend payments to shareholders, as firms rush to hold on to capital amid the continuing credit crisis and deteriorating economy."},{"Date":"2009-02-09T00:00:00.000","Headline":"Focus Stock: Smart Buys Boost Mylan","Summary":"Mylan (MYL) has undergone a corporate metamorphosis that has transformed the company from a U.S.-only midsize generic drugmaker into the third-largest player in the over $70 billion global generics market. This has been accomplished principally through the acquisitions of the generics division of German drugmaker Merck\u2014not related to U.S.-based Merck (MRK) for $6.9 billion in October 2007 (Merck Generics); and Matrix Laboratories, an India-based manufacturer of active pharmaceutical ingredients"},{"Date":"2009-02-25T00:00:00.000","Headline":"Seroquel Case: Must AstraZeneca Tell All?","Summary":"In more lawsuits, companies are being forced to reveal internal information during the pretrial discovery phase that otherwise would be kept private"},{"Date":"2009-02-26T00:00:00.000","Headline":"Carl Icahn's Dealmaking Heats Up","Summary":"Icahn's strategy is to secure board seats, then pressure management from inside for cost cuts, asset sales, or even outright mergers"},{"Date":"2009-03-18T00:00:00.000","Headline":"Analyst Picks and Pans: JAVA, GS, MS, INTC, LLY","Summary":"Sun Microsystems (JAVA)"},{"Date":"2009-04-03T00:00:00.000","Headline":"Amylin, Intercontinental, Kimco, MGM Mirage: U.S. Equity Movers","Summary":"Shares of the following companies are having unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 10:05 a.m. in New York."},{"Date":"2009-04-08T00:00:00.000","Headline":"The Next Wave of Open Innovation","Summary":"How InnoCentive aims to exploit sophisticated technology and networking capabilities to connect problems with their potential solvers"},{"Date":"2009-04-17T00:00:00.000","Headline":"Icahn's Blockbuster Move: So Far, a Bust","Summary":"The activist investor has seen the movie-rental chain go from troubled to worse, and now its viability is in doubt"},{"Date":"2009-05-04T00:00:00.000","Headline":"Marcial: Medarex, a Bright Spot in Biotech","Summary":"The world of biotechs is a tricky place for investors. Ambitious young companies aspiring to become future drug kings require huge financial resources to produce life-changing medicines that take many years to develop. Most firms never make it beyond the development stage. Nonetheless, some biotechs manage to reap enormous rewards once they reach near-commercialization of their products."},{"Date":"2009-05-04T00:00:00.000","Headline":"Pharma: The 10 Most Promising New Drugs","Summary":"The pharmaceutical industry continues to march toward the patent cliff in 2010-2012, when a record amount of drug sales will lose patent protection in the U.S. This means some of the best-selling drugs, including Pfizer's (PFE) Lipitor, Bristol-Myers Squibb's (BMY) Plavix and Avapro, Eli Lilly's (LLY) Zyprexa, Wyeth's (WYE) Effexor, and Merck's (MRK) Cozaar\/Hyzaar and Singulair will be exposed to generic competition."},{"Date":"2009-05-31T00:00:00.000","Headline":"Cancer Drugs: Herceptin News and More","Summary":"Editor's Note: An earlier version of this story incorrectly stated the percentage of breast cancer cases classified as triple negative, as well as the number of women who responded to the Astra-Zeneca drug, Olaparib."},{"Date":"2009-06-01T00:00:00.000","Headline":"Research Parks for the Knowledge Economy","Summary":"Since it opened 50 years ago, North Carolina's Research Triangle Park has been the epitome of science parks: a neatly landscaped campus of low-rise building buildings in exurbia, where scientists at aspiring technology spin-offs from nearby universities toil all day in cramped, low-rent \"incubators\" and then disperse each evening to fight the Interstate traffic on their way home."},{"Date":"2009-06-01T00:00:00.000","Headline":"Singapore's One North","Summary":"Yeoh Keat Chuan readily admits that Singapore doesn't have the world's hippest reputation. \"The concept used to be that if you are an expatriate with a family, go to Singapore because it is safe for your kids,\" says Yeoh, executive director of the biomedical sector for the nation's Economic Development Board. \"But if you are single and want to have fun, go to Hong Kong.\""},{"Date":"2009-06-10T00:00:00.000","Headline":"Actuant, ATP Oil, Eli Lilly, Palm, Vulcan: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 5:45 p.m. in New York."},{"Date":"2009-06-15T00:00:00.000","Headline":"Jobs: Top Cities for New College Grads","Summary":"Note: This is a revised version of this story. The original ranking relied on the Consumer Price Index as a cost-of-living measure. The new ranking uses data from the Council for Community and Economic Research, which is a better cost-of-living indicator."},{"Date":"2009-07-07T00:00:00.000","Headline":"Amylin, Arena, BPZ, Ruby Tuesday, Websense: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 5:40 p.m. in New York."},{"Date":"2009-07-08T00:00:00.000","Headline":"The Anatomy of an Entrepreneur","Summary":"This is a guest blog by Emily Schmitt, who joined BusinessWeek\u2019s Small Business team and Investing team in June."},{"Date":"2009-07-22T00:00:00.000","Headline":"Stocks Finish Mixed","Summary":"U.S. stocks closed mixed Wednesday, with the Dow industrials and S&P 500 lagging behind the Nasdaq composite index amid some profit taking on recent gains."},{"Date":"2009-08-11T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2009-08-13T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2009-08-18T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2009-08-19T00:00:00.000","Headline":"Tough Decisions on Osteoporosis Drugs","Summary":"Amgen (AMGN) and Eli Lilly (LLY) have endured some tough news in recent days on their experimental osteoporosis drugs. The companies' reactions provide investors with a clear picture of how pharmaceutical firms are adjusting their approaches to research and development in the face of a tougher, more safety-conscious Food & Drug Administration."},{"Date":"2009-08-19T00:00:00.000","Headline":"Eli Lilly, Hewlett-Packard, La-Z-Boy, SAIC: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses."},{"Date":"2009-08-21T00:00:00.000","Headline":"American Capital, Ariad, Morgan Stanley: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading on Aug. 24. Stock symbols are in parentheses."},{"Date":"2009-08-23T00:00:00.000","Headline":"CVS Caremark, Expedia, Priceline, Sears: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading on Aug. 24. Stock symbols are in parentheses."},{"Date":"2009-09-21T00:00:00.000","Headline":"Adolor, Louisiana-Pacific, Synnex, Yahoo: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 5:30 p.m. in New York."},{"Date":"2009-10-15T00:00:00.000","Headline":"An Asian Nanny State Ups Its Fun Factor","Summary":"Singapore has long enjoyed a reputation as the cleanest and least corrupt country in Southeast Asia, which may be why multinationals such as GE Energy (GE), Citibank (C), and Pfizer (PFE) have made it their home base in the region. But while it offers the kind of security that corporate planners like, Singapore is also known for being prim and punitive\u2014a place where chewing gum can't be sold and graffiti vandals have been sentenced to a half-dozen strokes of the cane."},{"Date":"2009-10-21T00:00:00.000","Headline":"Boeing, Eli Lilly, SanDisk, Stryker, Yahoo: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 9 a.m. in New York."},{"Date":"2009-10-21T00:00:00.000","Headline":"Stocks Hit by Late Sell-Off","Summary":"U.S. stocks closed lower Wednesday as late-day profit taking robbed the market of earlier gains."},{"Date":"2009-10-23T00:00:00.000","Headline":"Singapore Bets on Casino Gambling","Summary":"Singapore has long enjoyed a reputation as the cleanest and least corrupt city in Southeast Asia, which may be why multinationals such as GE Energy (GE), Citibank (C), and Pfizer (PFE) have made it their home base for the region. But while \u00adSingapore offers the kind of security that corporate strategic planners like, it's also, well, a bit stiff\u2014a place where chewing gum can only be sold by pharmacies and defacing public property with graffiti is punishable by a half-dozen swift strokes of the c"},{"Date":"2009-11-04T00:00:00.000","Headline":"Drugmakers' Payments Draw Heat","Summary":"By Harris Meyer"},{"Date":"2009-11-04T00:00:00.000","Headline":"Ask Your Doctor If This Ad Is Right for You","Summary":"Does it seem like you hear the phrase \"ask your doctor\" every time you turn on the TV? There's a reason. Drug companies spend about $5 billion a year in the U.S. on ads imploring people to talk to their physicians if they think a pill they've read about or seen on TV might help them. Such ads are so pervasive one might assume viewers are heading to the doctor knowing which drugs they want. But new research based on recordings of conversations in physicians' offices suggests most patients aren't"},{"Date":"2009-11-10T00:00:00.000","Headline":"Marcial: Is Eli Lilly Ripe for a Rebound?","Summary":"What's not to like about global pharmaceutical giant Eli Lilly (LLY)?"},{"Date":"2009-11-16T00:00:00.000","Headline":"Economic Recovery Inspires Innovation and Frustration","Summary":"While they continue to slog through the longest economic downturn in decades, companies are no longer making cost-cutting their primary focus. Innovation is now front and center on the corporate agenda, according to a global survey we recently conducted with 65 senior executives from diverse industries. Executives are adding more breakthrough innovations and business model changes to their portfolio to fuel the growth engine for the recovery. Yet our survey reveals that companies by and large ar"},{"Date":"2009-11-19T00:00:00.000","Headline":"Why Drugmakers Don't Twitter","Summary":"Some 60% of Americans say that when they need medical information, they turn to the Internet. At least half the group uses social networks to consult one another on symptoms, diagnoses, and treatments, according to surveys on Web behavior. Pharmaceutical companies would like to get in on the conversation, but how do these highly regulated companies twitter and friend without running afoul of federal marketing restrictions?"},{"Date":"2009-11-19T00:00:00.000","Headline":"Innovation Goes Downtown","Summary":"In its heyday decades ago, Olivetti employed nearly 3,000 workers in a hardscrabble section of Barcelona making typewriters. Drop into the former factory today, and you'll likely find young professionals perched on comfy foam couches talking business in a mix of languages amid brightly painted walls and exposed wooden beams. Glass-enclosed conference rooms are filled with students taking seminars on how to write business plans or develop marketing campaigns. Tacked to a bulletin board next to th"},{"Date":"2009-12-02T00:00:00.000","Headline":"Stock Picks: Apple, Lilly, Barrick Gold","Summary":"Wall Street analyst opinions on selected stocks in the news Wednesday"},{"Date":"2009-12-04T00:00:00.000","Headline":"Eli Lilly, Ford, Lockheed, Office Depot: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading on Dec. 7. Stock symbols are in parentheses."},{"Date":"2009-12-04T00:00:00.000","Headline":"Picks of the Week: Apple, AIG, Lilly, BofA","Summary":"Wall Street analysts give their buy, sell, or hold views on various stocks in the news this week"},{"Date":"2009-12-06T00:00:00.000","Headline":"Dow, Eli Lilly, Ford, Office Depot, Sprint: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses."},{"Date":"2009-12-07T00:00:00.000","Headline":"Aura Biosciences Targets a New Era of Cancer Drugs","Summary":"A Boston-based startup founded by a Spanish molecular biologist has devised a precise way to deliver chemotherapies inside nanotech protein shields"},{"Date":"2009-12-10T00:00:00.000","Headline":"Stocks on the Move: Anadarko, Citi, Gartner, Lilly","Summary":"Shares of the following companies are having unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 1:40 p.m. in New York."},{"Date":"2009-12-10T00:00:00.000","Headline":"The New Prominence of Comparative Drug Trials","Summary":"Roche announced on Dec. 2 that its experimental diabetes drug performed better in a trial than Merck's (MRK) $2 billion-a-year blockbuster Januvia. This gave the Swiss giant potent bragging rights\u2014and it was part of a pattern. Six weeks earlier, Roche trumpeted data showing its treatment was superior to a diabetes drug from Eli Lilly (LLY). Next year it will wrap up two more trials, pitting its drug against diabetes products from sanofi-aventis (SNY) and Japan's Takeda."},{"Date":"2009-12-10T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2009-12-11T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2009-12-21T00:00:00.000","Headline":"Stocks on the Move: Aetna, E*Trade, Intel, MetroPCS","Summary":"Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 10:00 a.m. in New York."},{"Date":"2010-02-08T00:00:00.000","Headline":"Health Care: Rx for MBA Job Blues","Summary":"For two years, MBAs have suffered mightily, as the credit crisis, recession, and bursting of the housing bubble have wreaked havoc on the job market. One by one, starting with investment banking, whole industries have erected \"MBAs Need Not Apply\" signs. One big exception is health care."},{"Date":"2010-02-12T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2010-02-12T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2010-02-25T00:00:00.000","Headline":"Eli Lilly's Drug Assembly Line","Summary":"Shortly after becoming CEO of Eli Lilly (LLY) in April 2008, John Lechleiter, a former lab scientist, sent senior executives a gift. It was a digital clock counting down, second by second, to Oct. 23, 2011. That's the day Lilly's $5 billion-a-year schizophrenia pill, Zyprexa, goes off patent. Next to the countdown were four words: \"Do what we do.\""},{"Date":"2010-03-11T00:00:00.000","Headline":"Did J&J Plan to Break Rules?","Summary":"Johnson & Johnson's (JNJ) Risperdal was, in some ways, a drugmaker's dream. At its peak in 2007, the antipsychosis medicine produced $4.5 billion in revenue. But it has also opened up a medicine cabinet full of legal woes. Lawsuits are now pending against J&J in 10 U.S. states for promoting Risperdal \"off-label\"\u2014meaning for uses the Food & Drug Administration did not approve. And in January of this year, the U.S. Justice Dept. sued J&J in a federal court in Boston, claiming the c"},{"Date":"2010-03-11T00:00:00.000","Headline":"Why MBAs are Going East","Summary":"James Tsai is the sort of MBA corporate recruiters covet. He went to a good prep school, earned a degree with honors from Middlebury College, and made vice-president in Bank of America's (BAC) international wealth management group at the age of 26. Today, Tsai is about to graduate, straight A's in hand, from Northwestern's Kellogg School of Management, a top-rated program in America. And he's hustling to land his first post-MBA job\u2014in China."},{"Date":"2010-03-24T00:00:00.000","Headline":"Obamacare's Cost Scalpel","Summary":"One often-heard criticism of the health-care reform legislation that President Barack Obama has now signed into law is that it won't do enough to rein in the cost of treatment. U.S. medical spending has soared to $2.5 trillion per year (a price tag that has more than doubled in 15 years) and represents 18% of the nation's gross domestic product. Can Obamacare begin to cope with that?"},{"Date":"2010-04-15T00:00:00.000","Headline":"YourEncore Keeps Retirees in the Game","Summary":"Some workers think of retirement as the day they'll close the door and walk away from their jobs forever. Not so the scientists and engineers who have signed on with YourEncore, a Web-based service that connects retirees with companies that need their expertise."},{"Date":"2010-04-28T00:00:00.000","Headline":"Amazon Looks to Widen Lead in Cloud Computing","Summary":"To widen its lead in the cloud computing market, Amazon.com is working to make its Web services compelling to more customers as computing giants such as Microsoft (MSFT) and IBM (IBM) attack the same territory."},{"Date":"2010-04-29T00:00:00.000","Headline":"Bail on Junk Bonds, Buy Up Cleantech","Summary":"It's hard to keep Americans from spending. The U.S. economy is improving at a faster rate than most people imagined it would, and the possibility of a double-dip recession is almost nil. The retail and consumer sector isn't great, but even it is coming in with a 3% growth rate year over year. Since interest rates will go up as the economy improves, I'm very lightly invested in bonds, and our biggest equity positions are in consumer electronics companies\u2014retailer Best Buy (BBY) and manufacturers"},{"Date":"2010-05-10T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Wendy Soong search was limited to options that are more than 10 days from expiration, have trading volume of at least 500 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2010-05-13T00:00:00.000","Headline":"Forest Laboratories' Globe-Trotting Profits","Summary":"With a swipe of his debit card in a Phoenix pharmacy, Tyler Hurst bought a $99 bottle of Lexapro and kicked off a 9,400-mile odyssey of international corporate tax avoidance. Each stop along the way\u2014an industrial park in Dublin, a skyscraper in Amsterdam, a palm-shaded law office in Bermuda\u2014helps the medicine's maker, Forest Laboratories (FRX), cut its income tax bill. Although all of Forest's Lexapro sales are in the U.S., the company moves profits generated by the world's third-best-selling an"},{"Date":"2010-05-20T00:00:00.000","Headline":"Stock Picks: Alkermes, DIRECTV, PetSmart, Walgreen","Summary":"Alkermes Inc.: Jesup & Lamont initiated coverage on shares of Alkermes Inc. (ALKS) with a buy rating and $15 price target on May 20."},{"Date":"2010-06-03T00:00:00.000","Headline":"The MBA Job Picture Brightens","Summary":"The job market for MBA graduates appears to be slowly bouncing back at a growing number of top business schools, with increased on-campus recruiting, an uptick in job postings, and more students walking away at graduation with a job offer in hand. At some of these schools, career services directors say recruiting is returning to levels not seen since before the global recession and economic meltdown threw a wrench into the once-buoyant MBA job market two years ago."},{"Date":"2010-06-17T00:00:00.000","Headline":"Mitch Daniels: Governing by the Numbers","Summary":"Indiana is one of 10 states that has seen its unemployment rate go down in the past year, from 10.5 percent in May 2009 to 9.8 percent in April 2010. It has a budget surplus and a triple-A bond rating. Property taxes and the state payroll have gone down. For the first time since the 1970s, more people are moving to the state than leaving."},{"Date":"2010-07-19T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Wendy Soong search was limited to options that are more than 10 days from expiration, have trading volume of at least 500 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2010-07-31T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2010-07-31T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-08-02T00:00:00.000","Headline":"In Search of Deans, B-Schools Eye Top Execs","Summary":"Search committees at business schools are increasingly considering chief executive officers for top administrative positions, with two business schools in Boston and New York recently tapping former CEOs to head up their schools as deans."},{"Date":"2010-08-10T00:00:00.000","Headline":"The End of Outsourcing (As We Know It)","Summary":"In the next five years outsourcing as we know it will disappear. The legion of Indian service providers will be sidelined or absorbed. U.S. and European companies that pioneered this corner of the high tech industry will suffer similar fates if they don't wake up. Who will emerge as the new leaders? Google (GOOG) and Amazon.com (AMZN), brands that we associate with search and retail, will become better known for outsourcing."},{"Date":"2010-08-13T00:00:00.000","Headline":"S&P 500 Stocks Biggest Weekly Changes in Target Price","Summary":"The following tables show the biggest increases and decreases in analysts\u2019 target price, according to Bloomberg data, for companies in the Standard & Poor\u2019s 500 Index from Aug. 6."},{"Date":"2010-08-26T00:00:00.000","Headline":"3PAR, J. Crew, Lilly, Netezza, OmniVision: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 5:15 p.m. in New York."},{"Date":"2010-08-31T00:00:00.000","Headline":"Eli Lilly, FormFactor, Netflix, Sysco: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses and prices are as of 4:55 p.m. in New York."},{"Date":"2010-08-31T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2010-08-31T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-09-10T00:00:00.000","Headline":"S&P 500 Changes in Short Interest as Percentage of Float","Summary":"The following tables show companies listed in the S&P 500 Index that have the largest changes in short interest as a percentage of shares available for trading as of the Aug. 31 settlement date."},{"Date":"2010-09-13T00:00:00.000","Headline":"Ironwood, Power Integrations, UIL, Wabash: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 5:30 p.m. in New York."},{"Date":"2010-09-30T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2010-09-30T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-10-05T00:00:00.000","Headline":"At GM, High-Performance Computing Curbs Test Costs","Summary":"The automakeralong with Boeing, DreamWorks, Eli Lilly, and other companiesis using high-performance computers that run at almost 1 petaflops to improve products we use every day"},{"Date":"2010-10-07T00:00:00.000","Headline":"Briefs","Summary":"Liverpool, historically England's most successful soccer club, will likely be sold to New England Sports Ventures, parent company of the Boston Red Sox, for $476 million. The sale to NESV, a Boston-based company owned by billionaire John W. Henry, is still subject to English Premier League approval and a legal challenge from Liverpool owners Tom Hicks and George Gillett, who say the offer is too low. The five-time European champion, which won the last of its 18 English league titles in 1990, was"},{"Date":"2010-10-31T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2010-10-31T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-11-10T00:00:00.000","Headline":"Briefs","Summary":"Tyco International, the world's largest maker of security systems, agreed to sell a majority stake in its electrical and metal products unit to buyout firm Clayton Dubilier & Rice for $720 million, withdrawing plans to spin off the division. Proceeds from the sale of the 51 percent stake will go toward accelerating share buybacks under a $1 billion program annonced on Sept. 8. The unit, which will operate as a standalone entity called Atkore International, makes items such as barbed razor ri"},{"Date":"2010-11-30T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2010-11-30T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-12-03T00:00:00.000","Headline":"S&P 500 Companies With Weekly Estimate Revisions","Summary":"The following tables detail changes in consensus estimates for companies in the Standard & Poor\u2019s 500 Index. The tables include estimates for the fourth and first quarter. Earnings estimates are provided by Bloomberg."},{"Date":"2010-12-09T00:00:00.000","Headline":"S&P 500 Companies With Weekly Estimate Revisions","Summary":"The following tables detail changes in consensus estimates for companies in the Standard & Poor\u2019s 500 Index. The tables include estimates for the fourth and first quarter. Earnings estimates are provided by Bloomberg."},{"Date":"2010-12-22T00:00:00.000","Headline":"Bed Bath & Beyond, Crocs, Micron, Wintrust: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 4:45 p.m. in New York."},{"Date":"2010-12-31T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-12-31T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2011-01-03T00:00:00.000","Headline":"New York Stock Exchange Short Interest as of Dec. 15","Summary":"The following is a complete listing of short interest positions on the New York Stock Exchange as of the Dec. 15 settlement date."},{"Date":"2011-01-20T00:00:00.000","Headline":"Eli Lilly, Google, Polycom, Tempur-Pedic: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 4:55 p.m. in New York."},{"Date":"2011-01-27T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for Jan. 27","Summary":"The following U.S. companies provided their financial outlooks today:"},{"Date":"2011-02-04T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Bloomberg News search was limited to options that are more than 10 days from expiration, have trading volume of at least 200 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2011-02-09T00:00:00.000","Headline":"Amazon's Cloud-Computing Guru Honed Skills Fixing Lamborghinis","Summary":"Amazon.com (AMZN) Vice-President James Hamilton's schooling in computer data centers started under the hood of a Lamborghini Countach."},{"Date":"2011-02-10T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Bloomberg News search was limited to options that are more than 10 days from expiration, have trading volume of at least 200 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2011-02-28T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2011-02-28T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2011-03-03T00:00:00.000","Headline":"The Cloud: Battle of the Tech Titans","Summary":"Amazon.com's (AMZN) squat Seattle headquarters looks nothing like the country club affairs found in Silicon Valley. There are no free soft drinks or volleyball courts. The light fixtures hanging from the ceiling in the reception area aren't fixtures at all but rather collections of extension cords fitted with bulbs. The receptionists lack computerized systems for registering guests. They simply write down visitors' names on a piece of paper. Such is low-margin life in online retail, where Wal-Ma"},{"Date":"2011-03-21T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Bloomberg News search was limited to options that are more than 10 days from expiration, have trading volume of at least 200 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2011-03-31T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2011-03-31T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2011-04-01T00:00:00.000","Headline":"S&P 500 Annual Meeting Calendar, Week of April 04 - 29","Summary":"The following table shows when companies in the Standard & Poor's 500 Index are scheduled to hold their annual meeting. Data is compiled by Bloomberg through company releases, stock exchanges and filings reported with the Securities and Exchange Commission."},{"Date":"2011-04-08T00:00:00.000","Headline":"S&P 500 Annual Meeting Calendar, Week of April 11 - May 06","Summary":"The following table shows when companies in the Standard & Poor's 500 Index are scheduled to hold their annual meeting. Data is compiled by Bloomberg through company releases, stock exchanges and filings reported with the Securities and Exchange Commission."},{"Date":"2011-05-06T00:00:00.000","Headline":"S&P 500 Stocks Biggest Weekly Changes in Target Price","Summary":"The following tables show the biggest increases and decreases in analysts\u2019 target price, according to Bloomberg data, for companies in the Standard & Poor\u2019s 500 Index from April 29."},{"Date":"2011-05-12T00:00:00.000","Headline":"Big Pharma Bets on a Novel Cancer Cure","Summary":"Drug companies have long hawked cancer treatments that either kill tumors outright with chemotherapy or use pricey medicines to block the mutated genes that fuel cancer's growth. Recently, drugmakers including GlaxoSmithKline (GSK), Eli Lilly (LLY), and Novartis (NVS) have begun chasing a third approach: reprogramming the aberrant DNA that can turn cells cancerous in the first place."},{"Date":"2011-05-13T00:00:00.000","Headline":"Renaissance Technologies Holdings in 1st Quarter: 13F Alert","Summary":"The following is an analysis of Renaissance Technologies LLC as of March 31, according to a filing with the U.S. Securities and Exchange Commission on 05\/13\/2011."},{"Date":"2011-05-16T00:00:00.000","Headline":"Fairholme Capital Mgmt Holdings in 1st Quarter: 13F Alert","Summary":"The following is an analysis of Fairholme Capital Management as of March 31, according to a filing with the U.S. Securities and Exchange Commission on 05\/16\/2011."},{"Date":"2011-05-26T00:00:00.000","Headline":"Cargo Theft: The New Highway Robbery","Summary":"At twilight on June 17, 2009, Ricky Gene McNew pulled his plum-red big rig into a TravelCenters of America (TA) truck stop in Denmark, Tenn. McNew had been driving all afternoon, starting from Louisville (Ky.), and hauling $10 million in pharmaceuticals. He was bound for Memphis, to the warehouse of a medical supply wholesaler. McNew filled his tank and headed into the truck stop for a shower. When he came out, his truck was gone."},{"Date":"2011-05-27T00:00:00.000","Headline":"As Doctors Limit Access, Pharma Taps Viscira for Simulations","Summary":"Veteran ophthalmologist Dr. Richard M. Wong has treated dozens of patients for macular degeneration, an age-related disease that leads to blindness. Though he trained with detailed drawings and photographs of the retina while he was a resident in 1996, he never learned what the condition was like from the patient\u2019s point of view."},{"Date":"2011-06-02T00:00:00.000","Headline":"A New Pricing Game for Drugmakers in Europe","Summary":"AstraZeneca (AZN) recently set the price of its new Brilique blood thinner, which it hopes will become its next blockbuster drug, at \u20ac1.69 ($2.38) per pill in Germany. Whether it will be allowed to maintain that price in Europe's largest drug market remains to be seen. The British drugmaker, insurers, and German regulators are bracing for a yearlong battle over the medicine's value, the first test of a new pricing law in Europe's biggest economy."},{"Date":"2011-06-03T00:00:00.000","Headline":"S&P 500 Stocks Biggest Weekly Changes in Target Price","Summary":"The following tables show the biggest increases and decreases in analysts\u2019 target price, according to Bloomberg data, for companies in the Standard & Poor\u2019s 500 Index from May 27."},{"Date":"2011-06-16T00:00:00.000","Headline":"When Two Cancer Drugs Are Better Than One","Summary":"Since 1998, when Roche Holding's Genentech won approval for the first of a new generation of personalized cancer medicines, drugmakers have rushed to develop compounds targeting specific genes and mutations responsible for cancer's growth. About two dozen targeted drugs have reached the market. An additional 800 medicines aimed at about 300 different genes are in development, says John Mendelsohn, president of the University of Texas MD Anderson Cancer Center. The methodology has produced some o"},{"Date":"2011-06-17T00:00:00.000","Headline":"The 25 Cheapest Cities in the U.S.","Summary":""},{"Date":"2011-06-21T00:00:00.000","Headline":"Finding a Big Enough Market Insight","Summary":"Why was Segway's two-wheeled vehicle a commercial failure while Zipcar's car-sharing service enabled its provider to raise $174 million following an initial public offering? Both companies offered affordable green transportation. Unlike Segway, Zipcar (ZIP) had what we call a BEMI\u2014a \"big enough market insight.\""},{"Date":"2011-07-21T00:00:00.000","Headline":"U.S. Companies Reporting Earnings on July 21","Summary":"The following table lists the 162 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2011-07-21T00:00:00.000","Headline":"U.S. Companies Reporting Positive EPS Surprises, July 21","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings estimates."},{"Date":"2011-07-21T00:00:00.000","Headline":"U.S. Companies Reporting Lower Quarterly EPS, July 21","Summary":"The following U.S. companies reported lower earnings per share for their latest quarter (end date of the quarter is noted in the last column)."},{"Date":"2011-07-21T00:00:00.000","Headline":"Midmorning Positive EPS Surprises for U.S. Companies, July 21","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings to earnings estimates."},{"Date":"2011-07-21T00:00:00.000","Headline":"AT&T, Lilly, Medco, PepsiCo, Travelers: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading today. Stock symbols are in parentheses and prices are as of 7:50 a.m. in New York."},{"Date":"2011-07-21T00:00:00.000","Headline":"U.S. Companies Reporting Midmorning EPS, July 21","Summary":"The following table lists the 114 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2011-08-23T00:00:00.000","Headline":"Caisse De Depot Holdings in 2nd Quarter: 13F Alert","Summary":"The following is an analysis of Caisse De Depot Et Placement Du Quebec as of June 30, according to a filing with the U.S. Securities and Exchange Commission on 08\/22\/2011."},{"Date":"2011-08-26T00:00:00.000","Headline":"Lumenogic Mines Workers\u2019 Opinions for Air Force, Multinationals","Summary":"To improve its aircraft, the U.S. Air Force typically relies on teams of seasoned engineers and bureaucratic procedures. But in December 2009, the Air Force\u2019s Rapid Reaction Innovation Team at Wright-Patterson Air Force Base in Dayton, Ohio, tried an unconventional approach: It asked workers at the Air Force Research Laboratory with less than five years on the job to develop their own proposals. Then some 2,000 personnel voted on the best ideas; ultimately the Air Force awarded $75,000 for proto"},{"Date":"2011-09-02T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Sept. 2."},{"Date":"2011-09-09T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Sept. 9."},{"Date":"2011-09-30T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Sept. 30."},{"Date":"2011-10-14T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Oct. 14."},{"Date":"2011-10-17T00:00:00.000","Headline":"Markit Group Announces Index to Measure Loan Returns","Summary":"Markit Group Ltd. has created a loan index to track the total return of 100 of the most liquid, dollar-denominated leveraged loans."},{"Date":"2011-10-18T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release"},{"Date":"2011-10-19T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release"},{"Date":"2011-10-20T00:00:00.000","Headline":"U.S. Companies Reporting Midmorning EPS, Oct. 20","Summary":"The following table lists the 89 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2011-10-20T00:00:00.000","Headline":"Midmorning Positive EPS Surprises for U.S. Companies, Oct. 20","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings to earnings estimates."},{"Date":"2011-10-20T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for Oct. 20","Summary":"The following U.S. companies provided their financial outlooks today:"},{"Date":"2011-10-21T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for the Week of Oct. 21","Summary":"The following U.S. companies provided their financial outlooks this week:"},{"Date":"2011-10-21T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Oct. 21."},{"Date":"2011-10-21T00:00:00.000","Headline":"S&P 500 Companies With Weekly Estimate Revisions","Summary":"The following tables detail changes in consensus for companies in the Standard & Poor\u2019s 500 Index. The tables include estimates for the third and fourth quarter. Earnings estimates are provided by Bloomberg."},{"Date":"2011-10-28T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Oct. 28."},{"Date":"2011-11-04T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Nov. 4."},{"Date":"2011-11-10T00:00:00.000","Headline":"Winton Capital Management Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Winton Capital Management Limited as of September 30, according to a filing with the U.S. Securities and Exchange Commission on 11\/10\/2011."},{"Date":"2011-11-11T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Nov. 11."},{"Date":"2011-11-14T00:00:00.000","Headline":"Renaissance Technologies Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Renaissance Technologies LLC as of September 30, according to a filing with the U.S. Securities and Exchange Commission on 11\/14\/2011."},{"Date":"2011-11-14T00:00:00.000","Headline":"Fairholme Capital Management Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Fairholme Capital Management as of September 30, according to a filing with the U.S. Securities and Exchange Commission on 11\/14\/2011."},{"Date":"2011-12-02T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Dec. 2."},{"Date":"2011-12-09T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Dec. 9."},{"Date":"2011-12-13T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Dec. 13."},{"Date":"2011-12-14T00:00:00.000","Headline":"Israeli Stocks: Clal Biotechnology Industries and RadVision","Summary":"Israel\u2019s TA-25 Index dropped for second time this week, retreating 0.7 percent to 1,069.40 at 1:56 p.m. in Tel Aviv."},{"Date":"2011-12-14T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Dec. 14."},{"Date":"2011-12-15T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Dec. 15."},{"Date":"2011-12-16T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Dec. 16."},{"Date":"2011-12-23T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Dec. 23."},{"Date":"2011-12-30T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Dec. 30."},{"Date":"2012-01-06T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for the Week of Jan. 6","Summary":"The following U.S. companies provided their financial outlooks this week:"},{"Date":"2012-01-06T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Jan. 6."},{"Date":"2012-01-06T00:00:00.000","Headline":"S&P 500 Stocks Biggest Weekly Changes in Target Price","Summary":"The following tables show the biggest increases and decreases in analysts\u2019 target price, according to Bloomberg data, for companies in the Standard & Poor\u2019s 500 Index from Dec. 30."},{"Date":"2012-01-09T00:00:00.000","Headline":"U.S. Company Profit Outlooks for Jan. 5: Table","Summary":"The following U.S. companies provided their financial outlooks today:"},{"Date":"2012-01-13T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Jan. 13."},{"Date":"2012-01-20T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Jan. 20."},{"Date":"2012-01-27T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Jan. 27."},{"Date":"2012-01-30T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release"},{"Date":"2012-01-31T00:00:00.000","Headline":"U.S. Companies Reporting Midmorning EPS, Jan. 31","Summary":"The following table lists the 72 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2012-01-31T00:00:00.000","Headline":"Midmorning Positive EPS Surprises for U.S. Companies, Jan. 31","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings to earnings estimates."},{"Date":"2012-01-31T00:00:00.000","Headline":"U.S. Companies Reporting Earnings on Jan. 31","Summary":"The following table lists the 55 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2012-01-31T00:00:00.000","Headline":"U.S. Companies Reporting Lower Quarterly EPS, Jan. 31","Summary":"The following U.S. companies reported lower earnings per share for their latest quarter (end date of the quarter is noted in the last column)."},{"Date":"2012-02-09T00:00:00.000","Headline":"Winton Capital Management Holdings in 4th Quarter: 13F Alert","Summary":"The following is an analysis of Winton Capital Management Limited as of Dec. 31, according to a filing with the U.S. Securities and Exchange Commission on Feb. 9."},{"Date":"2012-02-10T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Feb. 10."},{"Date":"2012-02-17T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Feb. 17."},{"Date":"2012-02-24T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Feb. 24."},{"Date":"2012-03-01T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Company","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor\u2019s 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest quarterly dividend paid divided by earnings."},{"Date":"2012-03-02T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of March 2."},{"Date":"2012-03-08T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of March 8."},{"Date":"2012-03-16T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of March 16."},{"Date":"2012-03-23T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of March 23."},{"Date":"2012-04-25T00:00:00.000","Headline":"Midmorning Positive EPS Surprises for U.S. Companies, April 25","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings to earnings estimates."},{"Date":"2012-04-25T00:00:00.000","Headline":"U.S. Companies Reporting Positive EPS Surprises, April 25","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings estimates."},{"Date":"2012-04-25T00:00:00.000","Headline":"U.S. Companies Reporting Earnings on April 25","Summary":"The following table lists the 179 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2012-04-25T00:00:00.000","Headline":"U.S. Companies Reporting Lower Quarterly EPS, April 25","Summary":"The following U.S. companies reported lower earnings per share for their latest quarter (end date of the quarter is noted in the last column)."},{"Date":"2012-04-26T00:00:00.000","Headline":"U.S. Companies Reporting Midmorning EPS, April 25","Summary":"The following table lists the 77 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2012-04-27T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for the Week of April 27","Summary":"The following U.S. companies provided their financial outlooks this week:"},{"Date":"2012-05-03T00:00:00.000","Headline":"Winton Capital Management Limited Holdings in 1st Quarter: 13F","Summary":"The following is an analysis of Winton Capital Management Limited as of Mar. 31, according to a filing with the U.S. Securities and Exchange Commission on May 3."},{"Date":"2012-07-06T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of July 6."},{"Date":"2012-07-13T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of July 13."},{"Date":"2012-09-07T00:00:00.000","Headline":"S&P 500 Stocks Biggest Weekly Changes in Target Price","Summary":"The following tables show the biggest increases and decreases in analysts\u2019 target price, according to Bloomberg data, for companies in the Standard & Poor\u2019s 500 Index from Aug. 31."},{"Date":"2012-09-14T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Sept. 14."},{"Date":"2012-09-21T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Sept. 21."},{"Date":"2012-09-28T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Sept. 28."},{"Date":"2012-10-05T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Oct. 5."},{"Date":"2012-10-11T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in Standard & Poor\u2019s 500 Index as of September 30. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2012-10-19T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Oct. 19."},{"Date":"2012-10-30T00:00:00.000","Headline":"Italy Battles French Tsarist Playground for Russia Riches","Summary":"Italy is battling France to become the new playground for Russia\u2019s billionaires as Europe\u2019s luxury destinations seek buyers of property and companies to weather the debt crisis."},{"Date":"2012-11-06T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor\u2019s 500 Index as of October 31. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2012-11-06T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor\u2019s 500 Index by industry as of October 31. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2013-02-14T00:00:00.000","Headline":"Renaissance Technologies Holdings in 4th Quarter: 13F Alert","Summary":"The following is an analysis of Renaissance Technologies LLC as of Dec 31, according to a filing with the U.S. Securities and Exchange Commission on Feb. 14."},{"Date":"2013-02-14T00:00:00.000","Headline":"Viking Global Investors Holdings in 4th Quarter: 13F Alert","Summary":"The following is an analysis of Viking Global Investors LP as of Dec. 31, according to a filing with the U.S. Securities and Exchange Commission on Feb 14."},{"Date":"2013-06-12T00:00:00.000","Headline":"Higher, Lower, Unchanged and Reversed EPS for S&P 500","Summary":"Here are the reported first quarter of 2013 earnings per share for companies in the Standard & Poor\u2019s 500 Index. Companies are divided by their reported year-over-year EPS differences (higher, lower, unchanged, reversals). Within groups, the companies are ranked by year-over-year percent changes."},{"Date":"2013-06-12T00:00:00.000","Headline":"EPS in the First Quarter of \u201913 for S&P 500 Stocks by Sectors","Summary":"Here are the cumulative earnings per share results for the first quarter of 2013 for Standard & Poor\u2019s 500 Index stocks, broken down into ten sectors: consumer discretionary, consumer staples, energy, financial, health care, industrials, information technology, materials, telecommunication services and utilities. Within sectors, the companies are ranked by year-over-year percent changes."},{"Date":"2013-06-12T00:00:00.000","Headline":"EPS in the First Quarter of \u201913 for S&P 500 Stocks by Industry","Summary":"Here are the cumulative earnings per share results for the first quarter of 2013 for Standard & Poor\u2019s 500 Index stocks broken down into 24 industries. Within industries, companies are ranked by year-over-year percent changes."},{"Date":"2013-06-12T00:00:00.000","Headline":"Positive EPS Surprises for First Quarter of \u201913 for S&P 500","Summary":"Following are positive and unchanged earnings surprises for the first quarter of 2013 for companies in the Standard & Poor\u2019s 500 Index. So far, 66.7 percent (331 out of 496) of the S&P 500 have reported positive surprises, and 9.1 percent (45 out of 496) have reported zero percent surprises."},{"Date":"2013-06-12T00:00:00.000","Headline":"Reported First Quarter EPS for S&P 500 Stocks as of June 12","Summary":"Following are the reported first quarter of 2013 earnings per share for companies in the Standard & Poor\u2019s 500 Index (end date of the quarter is noted in the last column). For the quarter-to-date, 498 companies out of 500 have reported their earnings. Companies are sorted alphabetically by ticker symbols."},{"Date":"2014-04-22T00:00:00.000","Headline":"Pharma Mergers Aren't a Miracle Cure","Summary":"Once a reliable source of large profits, the pharmaceutical industry is finding it harder and harder to make profitable new drugs."},{"Date":"2014-04-24T00:00:00.000","Headline":"U.S. PRE-MARKET MOVERS: AAPL ADES ANGI INFN QCOM SILC TNP TQNT","Summary":"Equity movers in early trading, with shrs traded pre-mkt:"},{"Date":"2014-05-30T00:00:00.000","Headline":"U.S. PRE-MARKET MOVERS: BIG BLOX BNNY EXPR NLNK OVTI PLX PSUN","Summary":"Equity movers in early trading, with shrs traded pre-mkt. Advancers: RTRX +21.4% (50.3k); Licenses Drug, Boosts Outlook, Gets Financing NLNK +10.9% (10.8k); Shows Efficacy With Tumor Regression, Immune Activation PLX +10.4% (36.7k); Reports Elelyso Approved in Canada BIG +10.3% (32.3k); Boosts Yr EPS View; 1Q EPS, Rev., Comps Beat Ests OVTI +10.2% (417.7k); 1Q Adj. EPS View Above Est.; Upgraded at Northland NMBL +4.2% (12.7k); 2Q Loss-Shr View In Line w\/ Est.; 1Q Loss-Shr Beats Est. ARRY +4% (5k"},{"Date":"2014-07-24T00:00:00.000","Headline":"U.S. PRE-MARKET MOVERS: ANGI CRUS DNKN FTNT ONVO QRE SKX TRIP","Summary":"Equity movers in early trading, with shrs traded pre-mkt: Advancers: ONVO +17.3% (238k); In Pact With JNJ Unit to Evaluate 3-D Bio-Printed Tissue VDSI +16.4% (19.6k); 2Q EPS Cont Ops 17c; Forecast Raised QRE +12.5% (35.7k); Breitburn Energy to Buy QR Energy for About $3.0b Incl. Debt FTNT +9% (2.1k); 2Q Adj. EPS, Rev. Beat Ests. SKX +8.4% (15.1k); 2Q EPS 68c, Gross Margin 45.9% FB +7.5% (6361.5k); 2Q Adj. EPS Beats, Mobile Ad Rev. 62% of Total UA +7% (124.4k); Raises Year Forecasts After 2Q Resu"},{"Date":"2014-11-14T00:00:00.000","Headline":"Tudor Investment Corporation Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Tudor Investment Corporation as of Sept. 30, according to a filing with the U.S. Securities and Exchange Commission on Nov 14. The tables compare the current quarterly filing with the previous one. Options, warrants and bonds are excluded."},{"Date":"2015-10-30T00:00:00.000","Headline":"Ackman: Valeant Strategy Difficult to Understand","Summary":""},{"Date":"2015-10-30T00:00:00.000","Headline":"Valeant to Sever Relationship With Philidor","Summary":""},{"Date":"2015-10-30T00:00:00.000","Headline":"Bill Ackman Stands With Valeant's Management","Summary":"Bill Ackman mentions on Pershing Square conference call on VRX the 10 largest settlement and judgments from 1991-2012 involving unlawful promotion of drugs and safety concerns, including cos. such as GSK, ABT, LLY, JNJ, MRK. Veritas Investment Research founding Partner Anthony Scilipoti and Bloomberg's Drew Armstrong and Julie Hyman speak on \"Bloomberg Markets.\" (Source: Bloomberg)"},{"Date":"2015-11-09T00:00:00.000","Headline":"Bloomberg\u2019s Elfin on Drug Pricing Subpoenas to MRK, LLY (Audio)","Summary":"Taking Stock with Kathleen Hays and Pimm Fox."},{"Date":"2016-11-03T00:00:00.000","Headline":"GOP Election Sweep May Help Financial, Drug Firms: Strategas","Summary":"In the event Republicans take control of House, Senate and White House on election day, their highest priority will likely be reform of corporate taxes and a move to a territorial tax system, Strategas head of policy research Dan Clifton writes in note. For investors, the big priority will be trying to understand what a President Trump means for international trade; notes presidents \"can impose tariffs by executive action\" Sets up a \"Republican Sweep\" basket of ETFs and stocks ETFs: Short S&"},{"Date":"2016-11-09T00:00:00.000","Headline":"U.S. ELECTION STREET WRAP: Biopharma M&A May Return","Summary":"Nasdaq Biotech pares gain to up 6% after rallying as much as 10% at the open after Trump election, healthcare second best performing sector after financials."},{"Date":"2018-04-23T00:00:00.000","Headline":"This Market Needs the FAANGs to Perform, Or Else: Taking Stock","Summary":"Stock futures are off highs with 10-year yields charging ever so closer to that 3% mark (peaked at 2.9957%). Commodities look mixed, with aluminum gaining more than 1% and Brent crude slipping back below $74 per barrel."},{"Date":"2018-06-04T00:00:00.000","Headline":"Traders Smash Buy Buttons Despite No Deal on China: Taking Stock","Summary":"S&P 500 futures are near overnight highs, and if all stays the same, we are looking to open at the highest since mid-March in an attempt to break above the recent 2,700-2,740 range. Most everything is green, aside from FB (down 1.3% on an NYT report shedding light on fresh privacy worries) and NXPI Semi (falling ~3% on China concerns)."},{"Date":"2018-06-08T00:00:00.000","Headline":"The Story of the Rothschild Forest Sold for $108 Million","Summary":"It\u2019s not easy to buy an Austrian forest. You need passion, roots in the local area and many millions."},{"Date":"2018-07-24T00:00:00.000","Headline":"Eli Lilly (LLY) Earnings: Good Quarter Masks Deeper Drug Risks","Summary":"Proposed drug-pricing changes that target middlemen could easily turn sour for the sector \u2014 and Lilly in particular."},{"Date":"2018-07-24T00:00:00.000","Headline":"Beat After Beat Launches Markets to Higher Ground: Taking Stock","Summary":"S&P 500 futures are climbing and poised to test the highs from last week, following strength in Europe (Stoxx 600 +0.9% on a bevy of well-received earnings reports) and China (Shanghai composite +1.6% on stimulus news)."},{"Date":"2018-09-12T00:00:00.000","Headline":"Wall Street Is Throwing in the Towel on the Semis: Taking Stock","Summary":"The stock market saw nothing but red last week, and it\u2019s been the opposite so far over the past two days."},{"Date":"2018-09-17T00:00:00.000","Headline":"Teva Analysts Say Migraine Drug Approval Gives Needed Relief","Summary":"Teva Pharmaceutical Industries Ltd. is up more than 8 percent pre-market in the U.S. after FDA approval of its migraine drug, Ajovy, surprised the Street. The medicine is the second of its kind, behind Amgen\u2019s Aimovig, and has the potential to reach sales of $1 billion in four years, according to BTIG analyst Timothy Chiang."},{"Date":"2018-09-20T00:00:00.000","Headline":"Lilly (LLY) Animal-Health IPO Elanco (ELAN) Makes Buyers Sit Up","Summary":"Investors hoping Eli Lilly's animal-health unit will do as well on its own as Pfizer's has stand to be disappointed."},{"Date":"2018-09-28T00:00:00.000","Headline":"Crowded Migraine Market Puts Drugmakers to the Test (LLY, TEVA)","Summary":"They\u2019re always saying they care more about volume than price. Here\u2019s a chance to prove it."},{"Date":"2018-11-27T00:00:00.000","Headline":"Have a Jho-lly Christmas","Summary":"This Christmas, Malaysians are spreading holiday cheer by poking fun of Jho Low, the man behind the #1MDB corruption scandal (Source: Bloomberg)"},{"Date":"2018-12-04T00:00:00.000","Headline":"Red-Hot Drug Stocks Reach New Highs Amid Trade Truce Skepticism","Summary":"The S&P 500 Pharmaceuticals Index rose as much as 1 percent to a record high, skirting a broad market sell-off as investors continued to shift into the high-momentum sector amid skepticism about the trade truce between the U.S. and China."},{"Date":"2018-12-19T00:00:00.000","Headline":"Blame the Fed, Blame FedEx, Blame Whoever You Want: Taking Stock","Summary":"There appear to be an endless amount of culprits that can be blamed for the latest downturn in the stock market."},{"Date":"2019-01-07T00:00:00.000","Headline":"Wall Street Cheers Lilly's $8 Billion Loxo Deal for Cancer Drugs","Summary":"Wall Street got another pleasant surprise on Monday morning, with Eli Lilly & Co. agreeing to buy Loxo Oncology Inc. for about $8 billion in cash. Most analysts applauded the deal, saying it boosts Lilly\u2019s growth profile and is consistent with its cancer strategy. The acquisition \u201cmakes sense for all,\u201d and the valuation looks right, according to Stifel."},{"Date":"2019-01-07T00:00:00.000","Headline":"Eli Lilly (LLY)-Loxo deal: Biotech Is Hot Place for M&A","Summary":"Big drugmakers have good reasons for pursuing deals, even if the rest of the M&A market cools."},{"Date":"2019-01-08T00:00:00.000","Headline":"What Samsung's Reaction to a Putrid Print May Mean: Taking Stock","Summary":"Tech is, oddly enough, starting to show shades of its pre-meltdown days."},{"Date":"2019-01-29T00:00:00.000","Headline":"China Trade Talks Overshadowed by China. And Trade: Taking Stock","Summary":"One could argue the four biggest developments overnight and into early trading are actually the most inconsequential, and futures are responding in kind near flat."},{"Date":"2019-01-30T00:00:00.000","Headline":"On Brink of Recession, Italian Executives Snub Rome, Take Action","Summary":"The northern industrial heartland is facing a new threat in 2019"},{"Date":"2019-02-06T00:00:00.000","Headline":"`Textbook' Bounce Doesn't Stop for Speeches: Taking Stock","Summary":"S&P futures dropped at 2 a.m. ET, but it had nothing to do with the State of the Union address, which mentioned little that was not previously telegraphed (vague mentions of infrastructure with little detail -- stocks to watch include materials and equipment firms EXP, USCR, MLM VMC, SUM, URI, HEES, HRI and even railroads like NSC, UNP). Attempts to lower drug pricing also was a focus, though details and nods to bipartisanship were scant, and as Raymond James points out, Senate Majority lead"},{"Date":"2019-02-27T00:00:00.000","Headline":"Incendiary, Synced Fireworks Risk Confusing Bulls: Taking Stock","Summary":"S&P futures are remarkably resilient early after fear-inducing headline alerts crossed smartphone and computer screens while the western hemisphere was sleeping."},{"Date":"2019-04-30T00:00:00.000","Headline":"Pfizer (PFE), Eli Lilly (LLY) Put Price Squeeze on Themselves","Summary":"Drugmakers are fighting for share in increasingly crowded markets of their own making."},{"Date":"2020-10-29T00:00:00.000","Headline":"Trump Got Regeneron's (REGN) Covid-19 Antibody Drug\u2014You Might Get Lilly's (LLY)","Summary":"Lilly plans to have 1 million doses available by yearend, far more at first than rival Regeneron\u2019s dual-antibody combo."},{"Date":"2020-12-11T00:00:00.000","Headline":"Tesla\u2019s S&P Entry Sets Up a Departure Later Today: Taking Stock","Summary":"Since news broke a month ago that Tesla Inc. will join the S&P 500 Index, investors have been left to wonder which company will be dropped to make room for the electric car maker. That wait will be over shortly after the markets close Friday."},{"Date":"2021-02-03T00:00:00.000","Headline":"Bitcoin Proselytizer Saylor Says Over 1,000 Firms Join Webinar","Summary":"Michael Saylor says he sees an \u201cavalanche\u201d of companies moving their cash into Bitcoin over the next 12 months.The chief executive officer of MicroStrategy Inc. and Bitcoin proselytizer made the projection at his company\u2019s World Now global conference that featured breakout sessions on the future of Bitcoin and how corporations can best position themselves to capitalize on the digital token. According to Saylor, 1,400 firms signed up for the session on Bitcoin legal considerations."},{"Date":"2022-06-14T00:00:00.000","Headline":"FDA Approves Alopecia Drug Olumiant From LLY, INCY to Treat Whole Body","Summary":"Federal regulators this week greenlit the first systemic treatment for alopecia, an autoimmune disorder that causes hair loss."},{"Date":"2022-08-03T00:00:00.000","Headline":"Lilly (LLY) Plans to Sell Covid-19 Antibody to Health-Care Providers, States","Summary":""},{"Date":"2023-01-13T00:00:00.000","Headline":"Lilly (LLY), Pfizer (PFE),  Amgen (AMGN) Crowd Into Hot Obesity Drug Market","Summary":"Three years ago, drugmakers and laboratories around the world responded to the pandemic with Covid-19 vaccines. Now that the urgency has faded, they\u2019re collectively turning attention to an older pandemic: obesity."},{"Date":"2023-01-19T00:00:00.000","Headline":"Lilly\u2019s (LLY) Donanemab Fails to Get Early Approval for Alzheimer\u2019s","Summary":""},{"Date":"2023-01-24T00:00:00.000","Headline":"Eli Lilly (LLY) Plans Manufacturing Expansion as Obesity Drug Demand Looms","Summary":"Eli Lilly & Co. will spend $450 million to expand a manufacturing site in North Carolina as demand grows for its diabetes drug that also has the potential to treat obesity."},{"Date":"2023-02-21T00:00:00.000","Headline":"Eli Lilly (LLY) Says Mounjaro Shortage Over After Drug Gets Weight-Loss Interest","Summary":"Eli Lilly & Co said on Tuesday that all doses of its new diabetes drug Mounjaro are now available after social-media enthusiasm about the drug\u2019s weight-loss benefits sparked a two-month-long shortage."},{"Date":"2023-02-21T00:00:00.000","Headline":"Eli Lilly (LLY) Says Mounjaro Shortage Over After Drug Gets Weight-Loss Interest","Summary":"Eli Lilly & Co said on Tuesday that all doses of its new diabetes drug Mounjaro are now available after social-media enthusiasm about the drug\u2019s weight-loss benefits sparked a two-month-long shortage."},{"Date":"2023-03-14T00:00:00.000","Headline":"Novo Nordisk (NOVOB) to Cut US Insulin Prices up to 75%, Following Lilly (LLY)","Summary":"Novo Nordisk A\/S, one of the world\u2019s biggest makers of insulin, said it would cut US prices for several of its products by up to 75%, following similar actions by rival Eli Lilly & Co."},{"Date":"2023-03-14T00:00:00.000","Headline":"Novo Nordisk (NOVOB) to Cut US Insulin Prices up to 75%, Following Lilly (LLY)","Summary":"Novo Nordisk A\/S, one of the world\u2019s biggest makers of insulin, said it would cut US prices for several of its products by up to 75%, following similar actions by rival Eli Lilly & Co."},{"Date":"2023-05-03T00:00:00.000","Headline":"Alzheimer\u2019s Disease Slowed by Eli Lilly (LLY) Drug Donanemab","Summary":"Eli Lilly & Co.\u2019s experimental drug for Alzheimer\u2019s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval."},{"Date":"2023-05-03T00:00:00.000","Headline":"Alzheimer\u2019s Disease Slowed by Eli Lilly (LLY) Drug Donanemab","Summary":"Eli Lilly & Co.\u2019s experimental drug for Alzheimer\u2019s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval."},{"Date":"2023-05-31T00:00:00.000","Headline":"Obesity Shot Frenzy Makes Lilly (LLY) World\u2019s Most Valuable Drugmaker","Summary":"Eli Lilly & Co.\u2019s third straight month of gains has helped it become the largest pharmaceutical company in the world by market value, surpassing Johnson & Johnson."},{"Date":"2023-05-31T00:00:00.000","Headline":"Obesity Shot Frenzy Makes Lilly (LLY) World\u2019s Most Valuable Drugmaker","Summary":"Eli Lilly & Co.\u2019s third straight month of gains has helped it become the largest pharmaceutical company in the world by market value, surpassing Johnson & Johnson."},{"Date":"2023-06-23T00:00:00.000","Headline":"Lilly\u2019s (LLY) Experimental Weight-Loss Pill Gets Rapid Results in Study","Summary":"Eli Lilly & Co.\u2019s experimental weight-loss pill helped patients shed pounds quickly in a mid-stage trial, setting the stage for competition to heat up with rivals such as Novo Nordisk A\/S that make obesity drugs."},{"Date":"2023-06-23T00:00:00.000","Headline":"Lilly\u2019s (LLY) Experimental Weight-Loss Pill Gets Rapid Results in Study","Summary":"Eli Lilly & Co.\u2019s experimental weight-loss pill helped patients shed pounds quickly in a mid-stage trial, setting the stage for competition to heat up with rivals such as Novo Nordisk A\/S that make obesity drugs."},{"Date":"2023-06-26T00:00:00.000","Headline":"Lilly\u2019s (LLY) Weight-Loss Shot Gives Company\u2019s Strongest Results in Trial","Summary":"An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any treatment yet, another boost for the company\u2019s efforts to dominate the burgeoning obesity drug market."},{"Date":"2023-06-26T00:00:00.000","Headline":"Lilly\u2019s (LLY) Weight-Loss Shot Gives Company\u2019s Strongest Results in Trial","Summary":"An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any treatment yet, another boost for the company\u2019s efforts to dominate the burgeoning obesity drug market."},{"Date":"2023-07-06T00:00:00.000","Headline":"A Wool Recycling Tradition Offers Lessons for Fast Fashion","Summary":"Demand for garments made from repurposed fabrics is rising as awareness builds about textile waste."},{"Date":"2023-07-06T00:00:00.000","Headline":"A Wool Recycling Tradition Offers Lessons for Fast Fashion","Summary":"Demand for garments made from repurposed fabrics is rising as awareness builds about textile waste."},{"Date":"2023-07-17T00:00:00.000","Headline":"Lilly (LLY) Applies for Alzheimer\u2019s Drug\u2019s US Approval After Trial Success","Summary":"Eli Lilly & Co. said it applied for full US approval of its Alzheimer\u2019s disease drug that\u2019s expected to compete with Eisai Co.\u2019s Leqembi as the US drugmaker revealed details of a final-stage trial at a conference in Amsterdam."},{"Date":"2023-07-17T00:00:00.000","Headline":"Lilly (LLY) Applies for Alzheimer\u2019s Drug\u2019s US Approval After Trial Success","Summary":"Eli Lilly & Co. said it applied for full US approval of its Alzheimer\u2019s disease drug that\u2019s expected to compete with Eisai Co.\u2019s Leqembi as the US drugmaker revealed details of a final-stage trial at a conference in Amsterdam."},{"Date":"2023-08-04T00:00:00.000","Headline":"Tinseltown Troubles, Television\u2019s Decline Irk Studios: US Earnings Week Ahead","Summary":"Next week\u2019s entertainment industry earnings are all about the labor disputes gripping Hollywood, as twin strikes by the Writers Guild of America and actors union SAG-Aftra rage on."},{"Date":"2023-08-04T00:00:00.000","Headline":"Tinseltown Troubles, Television\u2019s Decline Irk Studios: US Earnings Week Ahead","Summary":"Next week\u2019s entertainment industry earnings are all about the labor disputes gripping Hollywood, as twin strikes by the Writers Guild of America and actors union SAG-Aftra rage on."},{"Date":"2023-08-08T00:00:00.000","Headline":"Weight-Loss Stocks (LLY, WW) Soar as Novo (NVO) Results Spur Obesity-Drug Frenzy","Summary":"Wall Street\u2019s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo Nordisk A\/S obesity drug showed a heart benefit."},{"Date":"2023-08-08T00:00:00.000","Headline":"Weight-Loss Stocks (LLY, WW) Soar as Novo (NVO) Results Spur Obesity-Drug Frenzy","Summary":"Wall Street\u2019s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo Nordisk A\/S obesity drug showed a heart benefit."}]